The Importance of Facial Appearance in Patients With Eye Cancer by Brown, Nicola J
THE IMPORTANCE OF FACIAL APPEARANCE IN PATIENTS WITH
EYE CANCER
& RESEARCH PORTFOLIO
Nicola J. Brown 
(BSc Hons., MSc) 
August 2002
Submitted in partial fulfilment of the degree of Doctorate in Clinical Psychology, Department 
of Psychological Medicine, Faculty o f Medicine, University of Glasgow.
ProQuest Number: 13833910
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 13833910
Published by ProQuest LLC(2019). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
f , - r  riOW 
iii.WEBSnV 
11IBRARY: .
1X151
TABLE OF CONTENTS
PART ONE (this bound volume)
1. Small Scale Service Evaluation Project
Waiting Times and Attendance / Non-attendance in an Adult 
Clinical Psychology Department.
2. Major Research Literature Review
A Systematic Review of Studies that have examined the Impact of 
Facial Appearance Change in Eye Cancer and Head and Neck 
Cancer Patients.
3. Major Research Project Proposal
The Importance o f Facial Appearance in Patients with Eye Cancer.
4. Major Research Project Paper
The Importance of Facial Appearance in Patients with Eye Cancer.
5. Single Case Research Study (Abstract)
Targeting Self-esteem in the Treatment of Social Anxiety: A Single 
Case Experimental Design.
Pages
1-20
21-67
68-89
90-133
134-136
iii
Appendices
1. Small Scale Service Evaluation Project 137-138
1.1 Copy o f Notes for Contributors to Health Bulletin. 13 8
2. Major Research Project Literature Review 139-142
2.1 Copy of Notes for Contributors to Psycho-Oncology. 140-141
2.2 Observer-rated Disfigurement Scale. 142
3. Major Research Proposal 143-158
3.1 Participant Information Sheet. 144
3.2 Participant Consent form. 145
3.3 Appearance Schemas Inventory (ASI). 146
3.4 Appearance Schemas Inventory-face (ASI-face). 147
3.5 Body Image Ideals Questionnaire (BIQ). 148-151
3.6 Body Image Ideals Questionnaire-face (BIQ-face). 152-153
3.7 Standard instructions for PRISM and PRISM+. 154-155
3.8 Clinician-rated Facial Appearance change scale. 156
3.9 Letter confirming ethical approval. 157-158
4. Major Research Project Paper 159-162
4.1 Notes for Contributors to Psycho-Oncology. 160-161
4.2 Means and standard deviations for the Appearance Schemas 162 
Inventory (ASI) and the Body Image Ideals Questionnaire (BIQ).
iv
PART TWO (Separately bound volume; numbered from page 1)
Single Case Research Study
Targeting Self-esteem in the Treatment of Social Anxiety: A Single Case 
Experimental Design.
Appendices
1. Notes for contributors to Behavioural and Cognitive 
Psychotherapy.
2. Brief-Fear of Negative Evaluation Scale (Brief-FNE).
3. Comparison of experimental conditions using ITSACORR.
Pages
1-27
28-32
29-30
31
32
Acknowledgements
Firstly, I would like to thank Dr Craig White for his guidance and support throughout the 
whole research process. From the course team I would also like to thank Drs Liz Campbell 
and Andrew Gumley for guidance on the single n research case. I am also grateful to Drs 
Charlie Marsh and Clare Parkinson for their proofreading skills and to A lf Gillham whose 
help with the database was invaluable on the small-scale research project. For their 
enthusiasm and interest in the project, I want to acknowledge Dr Ewan Kemp (Consultant 
Ophthalmologist) and his team, in particular his secretary Donna Tidy. Also, many, many 
thanks go to friends and family for agreeing to be control participants. Most of all though I 
want to thank Roger for his constant support and patience throughout this research process.
1. SMALL SCALE SERVICE EVALUATION PROJECT
Waiting Time and Attendance / Non-Attendance in an Adult Clinical
Psychology Department
Prepared in accordance with the guidelines for submission to:
Health Bulletin 
(See Appendix 1.1 for notes to contributors).
2Waiting Time and Attendance / Non-Attendance in an Adult Clinical 
Psychology Department
Nicola J. Brown 
Department of Psychological Medicine 
University o f Glasgow 
Glasgow 
G12 0XH.
3Abstract
Objectives: To establish the distribution o f waiting times for a sample of referrals, and to 
determine the impact of waiting time on attendance and non-attendance.
D esign: Data in relation to time waiting for an appointment was retrieved from a 
departmental database. The rates of attendance and non-attendance were established in 
relation to waiting times, and further analyses made.
Setting : A West of Scotland adult department o f Clinical Psychology.
Subjects: All patients who were referred in a one-year period (1-1-98 to 31-12-98), and who 
had also been discharged at the time of data collection (April 2000): n=513 (57% female). 
Age range 18-99 years (mean 37.7 years).
Results: 341 (66.5%) referrals were Attenders (those who had attended at least one 
appointment), and 172 (33.5%) referrals were Non-Attenders (those who had never attended). 
The range o f waiting times was 0-51 weeks for Attenders, and 2-51 weeks for Non-Attenders. 
An independent samples t-test showed that the mean waiting time for Non-Attenders (27.4 
weeks) was significantly higher (t=5.52, df=511, two-tailed p<0.01) than that for Attenders 
(21.2 weeks).
Conclusions: The hypothesis that a shorter waiting time would be associated with higher rate 
o f attendance, and a longer waiting time with a decreased rate of attendance was supported. 
The rate of non-attendance was approximately 20% for those seen within 0-4 weeks, 
increasing to over 50% for those waiting 35 weeks or more. If, following an evaluation of a 
recently introduced opt-in system, this pattern o f waiting time and attendance continued, it is 
recommended that the department consider providing additional support for patients waiting 
35 weeks or more, in order to try and increase the rate o f attendance at this time.
4Introduction
Demand fo r  clinical psychology services
The 1993 British Psychological Society, Division of Clinical Psychology report1 described an 
NHS shortage of qualified clinical psychologists in the UK, coupled with a 20-100 per cent 
annual increase in demand for their services. At that time there were over 10,500 people 
waiting to see a clinical psychologist, with 44% of referrals being made to departments with 
waiting times of six months or longer. It is therefore not surprising that in the same survey 
only 15.5% of clinical psychologists felt that their services were meeting the demands made 
upon them. Conaghan et al. described how clinical psychology departments across the 
country are still “wrestling” with the problems of how to manage resources in the year 2000.
Non-Attendance o f  therapy
In a service already struggling to meet demands, patients’ failure to attend appointments 
therefore results in a substantial waste o f precious resources. The rates of non-attendance that 
are reported vary, as do definitions of non-attendance, with some researchers using the term to 
refer to patients who fail to attend only their initial appointment. For the purposes of this 
study, non-attendance was defined as never attending an appointment, and recent studies 
carried out in UK clinical psychology departments using this definition have found non- 
attendance rates to be generally high. For example, Keen et al. reported a non-attendance rate 
of 33% in their service in the East o f Scotland, while Loumidis and Shropshire4 reported an 
even higher rate o f non-attendance o f 52.6% in their service in the North of England.
5Waiting Time and Non-Attendance
Waiting time is generally defined as the time elapsed between being referred and receiving an 
appointment. Researchers have generally found an association between waiting time and non- 
attendance. For example, Morton5 found that non-attenders waited longer for an appointment 
than those who did attend. In addition, Loumidis and Shropshire4 found that waiting for more 
than six months was associated with non-attendance, and patients who had not attended 
waited an average of six weeks longer than attenders. However, Weighill et al.6 found that the 
interval time between referral and appointment was not related to non-attendance, although 
they did not specify how long patients had waited for an appointment.
Aims
• The first objective of the present study was to establish the distribution o f waiting times 
for a one-year sample of referrals in a West o f Scotland clinical psychology department.
• The second was to establish the impact o f waiting time on the rates of attendance and non- 
attendance, and to determine whether waiting time was a significant factor in attendance 
in this department.
Hypothesis
• Based on findings that, generally, non-attendance is associated with a prolonged waiting 
time, it was hypothesised that a shorter waiting time would be associated with higher rate 
of attendance, and a longer waiting time would be associated with a decreased rate of 
attendance.
6Method
Setting
The study was carried out in an adult Clinical Psychology department based in a psychiatric 
hospital in the West of Scotland. The department accepts both inpatient and outpatient 
referrals pertaining to patients residing in the catchment area. Clinics are held at both hospital 
and community sites. The department operates three categories of referral: Urgent, Priority 
and Routine (categorisation made according to allocation by the referrer). They aim to see all 
Urgent referrals within 0-3 weeks, and all Priority referrals within 9 weeks. Information is 
given to Routine patients explaining that their waiting time for an appointment will be 
approximately 20 weeks. The actual waiting time for Routine referrals depends primarily on 
how many Urgent and Priority referrals are waiting. Thus, it may be more or less than 20 
weeks. Re-grading of categorisation rarely occurs (in less than 5% of cases), and only occurs 
if requested by the referrer.
Subjects
The sample comprised all patients who were referred in a one-year period (1-1-98 to 31-12- 
98), and who had also been discharged at the time of data collection (April 2000). Referrals 
had to relate to patients that had been discharged, as in this department, data regarding 
attendance is not entered onto the database until the point of patient discharge. It was not 
possible from the database to distinguish inpatients from outpatients. Although the issues with 
respect to waiting time would be different for these two groups, the overall proportion of 
inpatients in this sample was known to be small (less than 5%). Thus it was felt that including 
inpatients would not greatly affect the outcome, which would mainly reflect the outpatients’ 
issues with respect to waiting time.
7Procedure
For each referral, the following fields were selected from an existing departmental “Access” 
database, and a hard copy produced:
• Gender (male, female)
• Age at time of referral (in years)
• Category of referral (Routine, Priority, or Urgent)
• Date of referral
• Date of first appointment
• No. of appointments attended
The data were then entered manually into “Excel”, and waiting time (in weeks) for each 
patient calculated from “Date of referral” to “Date o f first appointment”. Attendance data for 
each patient was assigned to one o f two groups, “Attenders” (i.e. those who had attended at 
least one appointment), or “Non-Attenders” (i.e. those who had never attended with number 
of appointments attended equal to zero).
Results were analysed in terms of waiting times and attendance using the SPSS statistical 
software package, and are reported in the section below.
Results
The total number of referrals for the period 1-1-98 to 31-12-98 that were eligible for inclusion 
was 513 (57% female). There was a wide range of ages: 18-99 years (mean 37.7 years). Of 
the referrals, 341 (66.5%) were Attenders (247 Routine referrals, 54 Priority referrals, and 40
Urgent referrals), and 172 (33.5%) were Non-Attenders (144 Routine referrals, 22 Priority 
referrals, and 6 Urgent referrals).
The range and mean waiting times (in weeks) for Attenders and Non-Attenders are shown in 
Table 1.
INSERT TABLE 1 ABOUT HERE
Each waiting time was rounded to the nearest whole number, and then grouped into one o f 
eleven five-week blocks of waiting time (five-week blocks were chosen as this best fitted the 
range of waiting times). The numbers of those attending, not attending, and the overall 
numbers for each of the eleven five-week blocks of waiting time are shown in Table 2. The 
distribution of waiting times according to referral category is shown in Figure 1.
INSERT TABLE 2 and FIGURE 1 ABOUT HERE
The relative percentages of attendance and non-attendance by patients, categorised according 
to block of waiting time, are shown in Figure 2.
INSERT FIGURE 2 ABOUT HERE
From Figure 2, it can be seen that as waiting time increases, the percentage o f those attending 
decreases. An independent samples t-test was performed to determine if waiting time was 
significantly different between the groups. There were no missing values, and data from all 
513 referrals were available for the analysis. The mean waiting time for Non-Attenders (27.4
9weeks) was found to be significantly higher (t=5.52, df=511, two-tailed p<0.01) than that for 
Attenders (21.2 weeks).
Hence, the hypothesis that a shorter waiting time would be associated with higher rate of 
attendance, and a longer waiting time would be found to be associated with a decreased rate 
o f attendance was supported.
Discussion
Distribution o f  Waiting Times
The first objective of this report was to obtain the distribution of waiting times for the sample. 
The overall range of waiting times was 0-51 weeks (see Table 1), and as can be seen from 
Figure 1, the modal waiting time was 20-24 weeks (n=104). A large number of patients 
(n=87) also waited for 25-29 weeks. The number o f patients waiting between 0-9 weeks 
(n=95) was higher than the number of patients waiting between 10-19 weeks (n=75). This can 
be explained by the department aiming to see Urgent cases in 0-3 weeks, and Priority cases in 
9 weeks. Hence, referrals seen in the 0-9 week period mostly reflect Urgent and Priority cases 
(see Figure 1).
Limitations o f  the Database
The “Date of first appointment” field for the Attenders related to the date of the first 
appointment “attended”, and is the only attendance date recorded on the existing database. It 
is currently not possible to differentiate between date of first appointment “offered”, and date 
of first appointment “attended”. Thus, the waiting time calculations for those patients who did 
not attend the first appointment (i.e. the first appointment “offered”), but attended a
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subsequent appointment (i.e. the first appointment “attended”) were flawed, whereby the 
patient would appear to have waited longer for an appointment than was the case.
The waiting time calculations for some patients who never attended were also potentially 
flawed for the same reason. That is, if a patient was to DNA or cancel their first appointment, 
request another appointment date from the department, but then DNA or cancel this second 
appointment too, it is not clear which o f the two appointment dates is currently being entered 
onto the database in the “Date of first appointment” field. If the date of the last appointment 
offered to the patient before discharge is being entered into this field, then it would appear 
that the patient waited longer for an appointment than was the case.
Approximately a third o f Urgent (n=31, 33%), and exactly half of Priority (n=38, 50%) 
referrals waited longer than the department’s aims of 0-3 weeks, and 9 weeks respectively. 
The flaws in the waiting time calculations described above could explain this for some of 
these referrals. However, because both the proportion o f patients who DNA their first 
appointment but then subsequently attend, and the number of patients who “double” DNA are 
not currently known, it is important that these flaws are considered within this context. It is 
therefore not possible to state exactly how many of the Urgent and Priority cases in this study 
waited longer than set out in the department’s aims.
Waiting Time and Attendance /  Non-Attendance
The second aim of the report was to establish the impact of waiting time on the rates of 
attendance and non-attendance, and to determine whether waiting time was a significant 
factor in attendance in this psychology department. The results (see Table 1) showed that 
there was a similar range of waiting times for Attenders (0-51 weeks) and Non-Attenders (2-
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51 weeks). However, the Attenders waited a mean of 21.2 weeks, which was approximately 6 
weeks less than the Non-Attenders (mean 27.4 weeks). There was an overall Non-Attendance 
rate of 33.5%, which was comparable to that reported by Keen et al. in their East of Scotland 
study.
As stated in the introduction, patients’ failure to attend appointments results in a substantial 
waste of precious resources. For this psychology department, a substantial amount of clinical 
time is being lost through non-attendance. Figure 2 shows that, although the rate o f non- 
attendance was approximately 20% for those seen within 0-4 weeks, it increased to nearly 
40% for those waiting 25-34 weeks. Once waiting time exceeded 35 weeks, the rate o f non- 
attendance was over 50%. This association between waiting time and attendance and non- 
attendance was shown to be statistically significant, supporting the hypothesis that a shorter 
waiting time would be associated with higher rate o f attendance, and a longer waiting time 
would be associated with a decreased rate of attendance.
Additional Factors in Attendance /  Non-Attendance
It is important to note that waiting time is not the only factor that determines attendance and 
non-attendance. Many other factors may have been important, but were not set out to be 
addressed in this study. For example factors such as Age, Gender, and Category of referral 
may have also been important in determining attendance. These could be examined in relation 
to attendance in future research. Factors such as there being a resolution of the problem by the 
patient themselves whilst on the waiting list, might also in some cases determine non- 
attendance of therapy. Hence, waiting time is not the only factor involved in a patient’s 
decision to either attend or not attend an appointment, and the results must be considered with 
that in mind.
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Recommendations fo r  service provision
As outlined earlier, the Attenders simply represented patients that had attended at least one 
appointment during the course of therapy prior to being discharged. Presently it is not 
possible to isolate from this group the patients who had DNA’d or cancelled their first or 
subsequent appointments but who then attended at a later date. This also had the effect of 
skewing the waiting time calculation for those cases making it appear that they had waited 
longer for an appointment than they actually had. It is therefore recommended that additional 
date field(s) be added to the existing database (such as “Date of first appointment offered”, 
and “Was the first appointment offered attended?”). This would also help to clarify which 
date should be used in data entry for the Non-Attenders. It would also be useful if  the service 
utilised the database to provide regular feedback about length of time waiting. This would be 
particularly useful with respect to the Urgent and Priority referrals, to help monitor if  they are 
waiting longer than set out in the department’s aims.
Like many other psychology departments in the UK, this department has recently undertaken 
a measure to reduce waiting lists, by introducing a waiting list initiative in the form of an opt- 
in system (this was not in operation for the sample of patients in the present study). The opt-in 
system requires patients nearing the top of the waiting list to confirm that they still wish to 
have an appointment. If a patient fails to reply after two weeks of the letter being sent out, 
they are taken off the waiting list. It is also felt that patients who confirm that they still wish 
to have an appointment would be more likely to attend.
In the present study, patients who waited for 35 weeks or more were particularly vulnerable to 
non-attendance. In future research, any effect that introducing the opt-in system had on the 
pattern of attendance and non-attendance in relation to waiting time could be established. In
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particular, it would be useful to establish whether, following opt-in, patients who waited for 
35 weeks or more were still vulnerable to non-attendance. If this pattern continued, even with 
patients who had opted-in, it is recommended that the department considers how it might look 
at providing some additional support to patients who will be coming off the waiting list at 35 
weeks, in order to try and increase the rate o f attendance at that time.
Conclusions
Despite some of the limitations of the current dataset described above, this study has 
highlighted that waiting time is an important factor in attendance and non-attendance in this 
adult clinical psychology department. The hypothesis that a shorter waiting time would be 
associated with higher rate of attendance, and a longer waiting time would be associated with 
a decreased rate o f attendance was supported. However, the importance of other additional 
factors in determining attendance was also highlighted.
It is recommended that the department monitors waiting times by utilising the database to 
provide feedback. This will help to identify Urgent and Priority cases that might potentially 
be waiting longer for an appointment than set out in the department’s aims. In addition, the 
study has highlighted that a substantial amount of clinical time is currently being lost through 
non-attendance in this department, particularly with waiting times of 35 weeks or more, 
whereby over 50% of patients are failing to attend. Following the recent introduction of an 
opt-in system, non-attendance could potentially be reduced at this “vulnerable” time, and it is 
recommended that this be evaluated in future research. However, if this pattern continues 
despite patients opting-in, it is recommended that the department consider how it might look
14
at providing some additional support to patients coming off the waiting list at 35 weeks, in 
order to try and increase the rate of attendance at that time.
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Summary
Eye cancer patients have to not only cope with a life threatening diagnosis, but also 
with a potentially altered facial appearance as a result o f treatment. Hence, their self- 
concept in relation to the appearance of their face may be threatened resulting in body 
image disturbances. This systematic review aims to establish the scope and quality of 
the existing body image / appearance research in an eye cancer population.
Only two studies met the inclusion criteria for the review and these authors did not 
base their investigations on any definition or model of body image. In addition, there 
were no dedicated, validated, questionnaires used that asked specifically about 
appearance. Due to the low number of studies identified, the review was expanded to 
include head and neck cancer patients. Here thirteen studies met the inclusion criteria. 
However, overall the research that had examined body image or appearance factors in 
head and neck cancer was also of generally poor quality.
It is difficult to draw definite conclusions owing to the paucity of the literature. 
Further work examining body image dimensions as the main focus of investigation in 
facial cancer is therefore needed, in order that this area is not further neglected.
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1. Introduction
There is evidence to suggest that there is a high prevalence of psychological disorder 
in cancer patients. For example, Derogatis et al. (1983) found that, using DSM-III 
criteria (American Psychiatric Association, 1980), 47% of cancer patients received a 
diagnosis. O f these patients, 85% were experiencing a disorder with depression or 
anxiety as the central symptom. Zabora et al. (2001) reported an overall prevalence 
rate o f distress of 20%. They concluded that there is a great need to identify high-risk 
patients through psychosocial screening in order to provide early intervention. Thus, 
given the distress experienced by many cancer patients, the importance o f clinicians’ 
understanding of psychosocial adjustment to cancer has been emphasised (Brennan, 
2001).
Eye and adnexa1 cancer is a rare form of cancer and is the only ocular disease that 
directly threatens life (Kleinstein and Lehman, 1977). It is associated with a five-year 
mortality rate of 35% and a ten-year mortality rate of nearly 50% (Cruickshanks et al., 
1999; Brandberg et al., 2000), with metastasis occurring mainly to the liver. There are 
only approximately 40 new cases recorded each year in Scotland, with a male: female 
ratio of approximately 1:1 (Harris et al., 1998). The most common primary intraocular 
(within the eye) malignancy is posterior uveal melanoma (melanomas derived from 
the pigmented uveal tract of the eye). This incorporates the iris, ciliary body and the 
choroid (the vascular coat of the eye between the sclera and the retina) (see Figure 1).
INSERT FIGURE 1 ABOUT HERE
1 For the purposes of this research, “eye cancer” will be used to refer to “eye and adnexa cancer”, 
whereby adnexa are the adjoining anatomical parts o f the eye.
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Factors that influence treatment choice in eye cancer patients include size, extent and 
location of the tumour. Patients who have medium or large sized tumours that are 
growing, can be managed with either radiotherapy or local resection of the tumour. 
Patients who have large tumours that have produced severe visual loss, are more 
likely to be managed by enucleation (removal of the eye) (Sisley, 1999). No 
differences in survival have been reported for patients treated by these methods of 
treatment. (Seddon et al., 1985).
Eye cancer patients like all cancer patients are therefore at risk of developing 
psychological disorders. In addition to having to cope with a life threatening 
diagnosis, they also have to cope with a potentially altered facial appearance as a 
result o f treatment. Therefore, self-concept may also be threatened resulting in 
disturbances in body image.
Higgins’ (1987) Self-Discrepancy Theory suggests that the “se lf’ has multiple aspects 
that develop through both internal self-evaluations and interpersonal experiences. 
These aspects are also dynamic as, in response to external events (such as a cancer 
diagnosis), they may be changed or modified. In this theory, two of the components 
are the ideal / self and the actual / self. Ideal / self refers to the aspirations as to who 
one could potentially be, whereas actual / self refers to conceptions as to who one 
really is. Higgins (1987) proposed that individuals are motivated to achieve a match 
between their ideal / self and actual / self because a discrepancy would result in 
psychological distress (experienced as either depression or anxiety). A diagnosis of 
cancer is particularly threatening to the ideal / self because it is associated with both 
fear o f pain and death due to the disease, and fears of painful and debilitating and
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possibly disfiguring treatment. Receiving a diagnosis of cancer is therefore a 
particularly potent motivation for engaging in adjustments related to the self (Curbow 
et al., 1990).
The Social Sciences Citation Index (SSCI) holds citation data from 1981 to 2002 and 
is updated monthly. Using this database, over 550 articles to date had cited Higgins 
(1987). The majority of the citations that had examined body image dimensions were 
within the eating disorders field and had focused on weight-related appearance. Only 
one study that had cited self-discrepancy theory had been carried out with cancer 
patients (Heidrich et al., 1994). They investigated whether or not self-discrepancies 
were related to psychological well-being and distress in twenty life domains by asking 
patients to rate ideal / self and actual / self in each domain. Items included “my 
physical health”, “coping with change” and “pursuing my leisure interests and 
hobbies”. The authors did not examine body image or appearance related issues in 
detail in these cancer patients as there was only one item relating to ideal / self and 
actual / self in the domain of “physical appearance”.
Cash and Szymanski (1995) highlighted that previous body image research has tended 
to regard all physical attributes as if  they were of equal importance. They proposed 
that it is the degree to which someone places importance on a perceived ideal / self 
actual self discrepancy that is important, and not merely the discrepancy being 
present. Thus, an ideal / actual self-discrepancy of major importance (i.e. one that has 
high investment) will have a significant psychological impact, being equivalent to 
having multiple ideal / actual self-discrepancies that are each associated with lesser 
degrees o f importance. By combining the concept of investment with Higgins’ (1987)
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self-discrepancy theory, they were able to account for the differential degrees of 
importance that are placed on physical features by different people.
Again using the Social Sciences Citation Index (SSCI), 17 studies to date had cited 
Cash and Szymanski (1995). Here the concept o f investment had been applied mainly 
to the eating disorders field in studies using college females and had not been used at 
all in cancer research.
Although the concepts of self-discrepancy theory and investment have not been 
widely applied to the cancer field in terms of body image research, it is not known 
what, if any, other body image research exists in patients with eye cancer. Thus a 
systematic review of studies that have examined the impact of facial appearance 
change in eye cancer patients is needed.
2. Systematic Review
2.1 Eye Cancer
This review aims to establish the scope and quality of the existing body image / 
appearance research in an eye cancer population.
Criteria for studies to be considered:
Study Designs
Randomised trials, cohort studies, case control studies and cross-sectional studies.
28
Participants
Patients aged 18 or over, where eye cancer is the primary diagnosis, with the onset of 
this occurring in adulthood.
Types o f Studies
Criteria for selection included literature that had addressed any or all o f the following 
as main outcome measure(s):
1. Body Image.
2. Appearance.
3. Disfigurement.
Search strategies for identification of studies:
Databases: Medline, PsycINFO, Embase, Cinahl, Cochrane Collaboration.
Years: 1967-2002 (up to and including June).
Search Terms:
1. All references to “body image”, or “appearance”, or “disfigurement” combined 
with: AND “eye cancer”, or “ocular cancer”, or “choroidal melanoma”, or 
“posterior uveal melanoma”.
2. All reference lists electronically identified were subsequently hand searched.
Methods of review
Selection of studies: All potential studies were reviewed by the author to determine if 
they fulfilled the inclusion criteria.
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Data Abstraction: Data were abstracted from each article relating to study design and 
quality, patient demographics, measurement instruments and outcomes.
Quality Assessment:
Studies were graded according to their design (Table 1). These gradings were based 
on quality gradings assigned by MacMahon and Lip (2002).
INSERT TABLE 1 ABOUT HERE
Summary of studies identified:
Eleven studies were identified that had reported on the issues listed above.
Excluded studies.
Nine studies in total were excluded:
Five studies were excluded on the basis that they did not meet study design criteria for 
inclusion:
• Two studies (Trunc et al, 1997; Damato, 2000) were editorials.
• One paper (Kennedy, 2000) was the narrative experience of an eye cancer
sufferer.
• One paper (Moy and Melia, 1999) was a descriptive outline of the design and 
methods of a future study: The Collaborative Ocular Melanoma Study.
• One study (Foss et al., 2000) described the development and validation of a
patient based measure of outcome in ocular melanoma.
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Three studies were excluded on the basis that they did not meet participant criteria for 
inclusion:
• One study (Hart et a l, 1998) had been carried out with ophthalmologists and 
not patients.
• In one study (Linberg et a l, 1988), only eighteen out of the sample o f one 
hundred and twenty five patients had had enucleations as a result of 
intraocular tumour. The majority of the enucleations (84 out of 125) had been 
performed as a result of ocular trauma.
• In another study (Rubin et a l, 1998), only four out of the sample of thirty-nine 
patients had had enucleations as a result of intraocular tumour. The majority of 
the enucleations (31 out of 39) had been performed as a result of ocular 
trauma.
One study was excluded on the basis that it failed to meet both participant criteria and 
study design criteria for inclusion:
• Webb (1990) had described the establishment of a support group for parents of 
children with eye cancer.
Included studies
There were only two studies (Brandberg et al., 2000; Bunston et al, 1994) that met 
the inclusion criteria for this review.
Design
Both studies (Brandberg et al, 2000; Bunston et al, 1994) had investigated 
appearance factors using a cross-sectional design.
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Setting
One study was carried out in Canada (Bunston et a l, 1994) and the other in Sweden 
(Brandberg et al., 2000). See Table 2 for a summary o f these studies.
INSERT TABLE 2 ABOUT HERE
Discussion of the two included studies
The study by Bunston et al. (1994) was carried out in two phases. The first phase was 
the development and verification of the reliability and validity of an inventory to 
identify the non-medical concerns o f ocular melanoma patients, which would be used 
in the second phase. This resulted in an inventory of 58 non-medical concerns o f the 
patients organised into fourteen need/concern domains, one of which was ‘self 
image’. They stated that their validation process had involved examining content, 
concurrent, convergent/divergent validity and test re-test reliability. However, they 
did not report any validity figures for these procedures. It was therefore unclear what 
the validity and reliability of the instrument actually was.
In the second phase, a cross-sectional study of 96 patients with ocular melanoma was 
carried out using the measure derived in the first phase. A criticism of this approach 
was that the patients were not divided into groups, which meant there were no 
comparisons made. Concerns were simply identified as being present in each domain 
if each patient had identified one or more need. Thirty-eight patients (39.6%) 
expressed concern regarding self image. However, the authors did not specify how 
many needs were in each domain, nor did they report any of the items. It was
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therefore difficult to ascertain to what extent there was concern in relation to self 
image.
Overall the layout o f this paper was poor, which had an adverse effect on its clarity. 
The authors appear to have attempted to fit too much into one paper, with the result of 
the overall quality being compromised.
Brandberg et al. (2000) examined psychological reactions in 99 patients with 
posterior uveal melanoma. The Eye Symptom Questionnaire, (Brandberg et a l, 2000) 
was administered one year following treatment. This is a non-validated 15-item 
questionnaire, which was developed for the study. It is now also being developed 
further for the ‘ophthalmic module’ of the European Organisation for Research and 
Treatment o f Cancer Quality of Life Questionnaire (EORTC QLQ-C30, Aaronson et 
al, 1993). The Eye Symptom Questionnaire included two items asking about 
appearance. These were rated by the patient on a four point Likert type scale in 
relation to the previous week. Ratings were: ‘not at all’, ‘a little’, ‘quite a bit’, or ‘very 
much’. The two items were:
1) Has your appearance bothered you?
2) Were you dissatisfied with the cosmetic result o f the surgery?
The authors compared those treated with ruthenium plaque therapy (n=32) to those 
treated with enucleation (n=46). They found that a higher percentage of those who 
were treated with enucleation had problems with appearance (54.6%) compared to 
those treated with ruthenium plaque therapy (13.2%) based on these two questions.
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The eye symptom questionnaire has not yet been adequately validated and therefore 
the results have to be interpreted within these constraints.
Conclusions
This systematic review has established that the existing literature examining body 
image and appearance in an eye cancer population is extremely sparse. In addition it 
has shown that what does exist is limited both in scope and quality. Only two research 
papers had investigated appearance issues in an eye cancer population, and their 
investigations were not based on any definition, theory or model of body image. In 
addition there were no dedicated, validated, questionnaires used that asked 
specifically about appearance. Instead their enquiries only extended to one or two 
questions relating to appearance out of a whole battery of measures. Perhaps this lack 
of research reflects the fact that eye cancer is a rare form of cancer.
Due to the low number of studies identified, it was not possible to draw any definite 
conclusions about the experience of facial appearance change as a result of eye 
cancer. Hence, the review was widened to also include head and neck cancer patients.
2.2 Head and Neck Cancer
Cancer of the head and neck is more common than eye cancer and accounts for 
approximately 5% of all malignant tumours (Million et al., 1989). As a result it is 
likely to have attracted more research interest than eye cancer. Strictly speaking, the 
term ‘head and neck’ cancer incorporates all cancers that develop in the oral cavity 
and sinuses, the ears, nose, lips, mandible (principal bone in the lower jaw), larynx,
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pharynx, and oesophagus (Petrucci and Harwick, 1984). However, sometimes oral 
cancers are described separately to head and neck cancer.
Head and neck cancer surgery may involve a laryngectomy (surgical removal o f all or 
part of the larynx), the partial or total removal of a tongue or mandible, or the loss of 
an ear among other disfigurations. Speech is often affected and, postoperatively, 
patients are often confronted with a permanent tracheal opening, a limited range of 
motion in the upper extremity, modifications in eating and grooming and obvious 
changes in appearance.
There are obvious similarities between eye cancer and head and neck cancer. They 
each affect vital functions, i.e. sight (eye cancer), swallowing and speech (head and 
neck cancer). In addition, visible facial disfigurement may result from either the 
treatment and/or the disease in both conditions. On this basis, it was deemed to be 
appropriate to expand the terms of this review to incorporate head and neck cancer 
(including oral cancer) literature that had examined appearance as a primary outcome 
in facial disfigurement in order to help inform the current status of body image 
research in facial cancers.
Criteria for studies to be considered:
Study Designs
Randomised trials, cohort studies, case control studies and cross-sectional studies.
35
Participants
Patients aged 18 or over, with head and neck / oral cancer as the primary diagnosis, 
with the onset of this occurring in adulthood.
Types o f Studies
Criteria for selection included literature that had addressed the following issues:
1. Body Image.
2. Appearance.
3. Disfigurement.
Search strategies for identification of studies:
Databases: Medline, PsycINFO, Embase, Cinahl, Cochrane Collaboration 
Years: 1967-2002 (up to and including June).
Search Strategies:
1. All references to “body image”, or “appearance”, or “disfigurement” 
combined with: AND “head and neck cancer”, or “oral cancer” or “facial 
cancer”.
2. All reference lists electronically identified were subsequently hand searched. 
Methods o f review
Selection of studies: All potential studies were reviewed by the author to determine if 
they fulfilled the inclusion criteria.
Data Abstraction: Data were abstracted from each article relating to study design and 
quality, patient demographics, measurement instruments and outcomes.
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Quality Assessment: Studies were graded according to their design (Table 1). 
Summary of studies identified
Twenty seven studies were identified that had investigated body image, appearance or 
disfigurement as a main outcome variable in head and neck cancer patients.
Excluded studies.
Fourteen studies in total were excluded:
Thirteen studies were excluded on the basis that they did not meet study design 
criteria for inclusion:
• Three studies (Morris, 1994; Owen et al., 2001; Rogers, 2001) were editorials.
• Ten studies (Anand and Anand, 1997; Bronheim et al., 1991; David and 
Barritt, 1982; Droughton, 1990; Koster and Bergsma, 1990; McQuellon and 
Hurt, 1997; Shapiro and Komfeld, 1987; Strauss, 1989; Turns and Sands, 
1978; van Doorne et al., 1994) were descriptive.
One study was excluded on the basis that it did not meet participant criteria for 
inclusion:
• Lockhart (1999) was a study of nurses’ perceptions of severity of facial 
disfigurement in head and neck cancer patients following surgery.
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Included studies
There were 13 studies (Baker, 1992; Devine et al., 2001; Dhillon et a l, 1982; 
Dropkin, 1979; Dropkin, 1999; Dropkin, 2001; Freedlander et al., 1989; Gamba et al., 
1992; Krouse et al., 1989; Kwok et al., 2002; Monga et al., 1997; M orton et al., 1984; 
West, 1977) that met the inclusion criteria for this review.
Design
Twelve studies (Baker, 1992; Devine et al., 2001; Dhillon et al., 1982; Dropkin, 1979; 
Dropkin, 1999; Dropkin, 2001; Freedlander et al., 1989; Gamba et al., 1992; Kwok et 
al., 2002; Monga et al., 1997; Morton et al., 1984; West, 1977) were cross-sectional 
designs. One study (Krouse et al., 1989) was prospective longitudinal in  design.
Setting:
One study was carried out in Scotland (Freedlander et al., 1989), one study (Kwok et 
al., 2002) in New Zealand, seven in the United States (Baker, 1992; Dropkin, 1979; 
Dropkin, 1999; Dropkin 2001; Krouse et al., 1989; Monga et al., 1997; West 1977), 
one in Italy (Gamba et al., 1992), and three in England, (Devine et al.., 2001; Morton 
et al., 1984; Dhillon et al., 1982). See Tables 3a and 3b for a summary of these 
studies.
INSERT TABLE 3A AND 3B ABOUT HERE
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There were two types of study identified:
a) Studies investigating the impact of disfigurement from head and neck cancer on 
another outcome variable.
The variables investigated were:
• Social adjustment patterns (West, 1977).
• Social interaction (Dropkin, 1979).
• Rehabilitation (i.e. eating, recreation, sleep, home life, work) (Baker, 1992).
• Self image (Gamba et al., 1992).
• Coping and length of stay in hospital (Dropkin, 1999).
• Post-operative levels of anxiety (Dropkin, 2001).
• Sexual functioning (Monga et a l., 1997).
b) Studies assessing the effect of having head and neck cancer on body image or 
appearance as a main outcome variable.
i) Cross-sectional
These studies all assessed the effects of different treatments for head and neck cancer 
on body image or appearance (Devine et a l, 2001; Dhillon et al., 1982; Freedlander et 
al., 1989; Kwok et al., 2002; Morton et a l, 1984).
ii) Prospective longitudinal
This study assessed body image as a main outcome variable (Krouse et a l, 1989) 
without comparing groups.
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Critical discussion of the included head and neck cancer studies in chronological 
order
The studies are reviewed in chronological order to establish if the era of publication 
had any bearing on the quality of the study produced.
An early study (West, 1977) investigated social adjustment patterns o f facially 
disfigured head and neck cancer patients. The inclusion criterion was ‘a visible 
disfigurement’. However, there was no definition of what constituted a visible 
disfigurement and it was assigned without the guidance of a scale. Social adaptation 
was ascertained by asking patients how well they had adapted to being disfigured in 
fourteen areas (including socialising with work colleagues and going out in public) 
using a non-standardised measurement tool. It was concluded simply that 86.2% of 
people had adapted “very well” to being disfigured. It was unclear how this 
conclusion was reached.
Dropkin (1979) was a particularly poor quality of paper achieving the lowest quality 
grading possible. The sample size was small (n=10) and they were all male. Degree of 
a patient’s deformity was assigned a number but there was no further reference to 
either how this number was assigned, or what it meant. Degree of deformity was 
compared to time spent out of hospital bedroom and this was recorded by nursing 
staff. Dropkin (1979) reported that the more disfigured the patient was post- 
operatively, the less time he spent voluntarily out of his room. She concluded that this 
suggested that social interaction decreased as deformity increased. However, there 
could have been any number of reasons why the patient decided not to come out o f his
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room. For example, higher deformity may have been associated with more pain, but 
the patients were not asked to contribute their opinions to the study.
Unlike either of the studies reviewed so far, Dhillon et al. (1982) set out to establish 
the patient’s view of the extent of their disfigurement following laryngectomy (n=35), 
or commando (excision of a primary tumour in the oral cavity combined with radical 
neck dissection and flap repair) (n=14) procedures. The ‘cosmetic’ assessment was 
achieved by means of a questionnaire that the patients were asked to return to the 
investigator by mail. The contents of this questionnaire were not described in the 
paper, therefore it is impossible to ascertain what the patients were asked.
It was reported that four patients (28%) considered themselves ‘severely’ disfigured 
and four (28%) ‘moderately’ disfigured by the commando operation. In contrast, the 
laryngectomy procedure had changed the facial appearance of only one patient 
(2.8%). The authors did not report any further results from the questionnaire. Hence, it 
is impossible to know how the remaining patients felt about their appearance. For 
example, it would have been useful to know whether or not any o f the laryngectomy 
patients felt ‘moderately’ disfigured and how many patients felt mildly or not 
disfigured. In addition, the number of patients in the commando group was fairly low 
so the result must interpreted within the constraints of this.
Morton et al. (1984) set out to assess the effects of treatment type on quantitative 
measures o f quality of life where appearance was one of the main outcomes. Overall 
they had a reasonable number of patients (n=48), although they were all male. In 
order to provide three groups for the purpose of comparisons they divided the patients
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up into Radiotherapy alone (n=19), Salvage surgery after failed radiotherapy (n=17) 
and Surgery alone (n=12). This meant the numbers in each group were fairly low.
The appearance measure used was the Body Satisfaction Scale. This was a non­
standardised in-house measure that was constructed for the purpose of their research. 
Patients were asked to rate satisfaction with the appearance of named parts of the 
body using a four-point scale. However, the authors did not give any details about the 
types of body parts that had been included. They also did not provide any scoring 
information, except to state that a high score indicated ‘dissatisfaction’ with several 
body parts and that the maximum score was ‘seven’. They also stated that only 
‘explicit dissatisfaction’ with a body part was scored, without any definition of what 
constituted explicit dissatisfaction or further explanation as to how this was decided.
They concluded that overall 53% felt that their looks had been affected and that the 
salvage surgery after failed radiotherapy group had the highest body dissatisfaction, 
followed by the surgery alone group. They did not state what statistical procedures 
had been used and did not consider the power of these calculations given the low 
number of patients in each group. It was difficult to interpret how they had arrived at 
these conclusions with such little information about the scale reported.
In a brief paper, Freedlander et al. (1989) asked 41 patients about their concern for 
appearance following major surgery for intraoral malignancy. Following neck 
dissection, patients who had had reconstructive surgery were compared according to 
the type of procedure they had. Reconstruction was achieved by either a free radical 
forearm flap procedure (n=27), or a distant pedicled flap procedure (e.g. involving the
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forehead) (n=14). The authors did not provide any further descriptive detail about the 
differences between these two procedures. They used an in-house measure to establish 
any embarrassment the patients had experienced in relation to their appearance, the 
details of which were not reported. They reported that there was no significant 
difference between the groups and that overall 20-25% had moderate to severe 
embarrassment in relation to their appearance. In addition, 15% of men compared to 
43% of women were concerned about their appearance. The limitations of this study 
were that the patient numbers in groups were quite low and the measure used was not 
validated.
Krouse et al. (1989) carried out a prospective longitudinal assessment of adults who 
had undergone surgery for head and neck cancer pre-operatively, at 3 months and 9- 
12 months post-operatively to assess body image as a main outcome variable. They 
used a non-standardised measure, the Body Image Questionnaire (Berscheid et al. 
1972). The sample size was quite small (n=33) and they did not make any group 
comparisons. They reported that 95% of the patients rated their appearance as 
‘average’ to ‘excellent’ pre-operatively and that this percentage remained constant 
post-operatively over a one year period. Thus they concluded that body image and 
appearance did not contribute significantly to post-operative adjustment. Although 
they had three time points for data from the Body Image Questionnaire, as this is a 
non-standardised tool, these conclusions must be considered within these constraints.
Baker (1992) set out to determine the relationship o f facial disfigurement to 
rehabilitation outcomes. Some progress in establishing the presence of disfigurement 
was made in this study compared to the two earlier studies, in that a scale was used.
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Extent of facial disfigurement was recorded using the Disfigurement-Dysfunction 
(D/D) scale (Dropkin et al. 1983).
The D/D scale was developed based on the ratings of registered nurses of photographs 
o f patients with simulated defects intended to represent eleven specific surgical 
procedures. Each procedure was rated as ‘no disfigurement’, ‘minor’, ‘moderate’ or 
‘severe’. However, by using the type o f surgical procedure as the means of 
determining the degree of disfigurement, this scale does not take into account 
individual differences in the cosmetic result attributable to differences in 
reconstructive technique, previous radiation, or occurrence of post-operative 
complications. In addition, the reported reliability and validity is limited to consensus 
by “a panel of experts” but they did not state what this consensus involved.
Baker (1992) reported that a high degree of facial disfigurement was associated with 
problems with eating and recreation, but it was not associated with sleep, home 
management or work. On this basis, they concluded that facial disfigurement was not 
an impediment to successful rehabilitation in head and neck cancer. As the design was 
correlational, it is not methodologically sound to draw this conclusion. Another major 
criticism is that the subjective experience of patients was not included, as they were 
not asked about their body image, with degree of disfigurement being assigned only 
by the investigator.
Gamba et al. (1992) set out to establish extent to which disfigurement affected self- 
image, relationship with partner, family and friends and overall impact o f therapy. 
They compared those with minor disfigurement (n=24) to those with extensive
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disfigurement (n=42). Although this study is an improvement on earlier studies 
because it has used group comparisons, a criticism is that the assignment of 
disfigurement as either minor or major was not achieved by using a scale. Instead a 
Physician’s opinion and not patient’s perception was used to allocate the patients to 
either the minor or extensive disfigurement groups, compromising the reliability of 
group allocation.
Gamba et al. (1992) reported that more of the extensively disfigured patients had a 
changed self image (57%) compared to the minor disfigured group (25%). However, 
this was ascertained by a non-standardised measurement tool assessing self image 
without any theoretical basis. In addition, although they reported changed self image, 
they do not extend this enquiry to find out how self image had changed. Therefore, 
this study is limited in terms of what it contributes to body image research.
Monga et al. (1997) examined the relationship between sexual functioning and 
disfigurement in patients with head and neck cancer using the clinician administered 
D/D scale (Dropkin et al., 1983) and the Derogatis Inventory of Sexual Functioning 
(Derogatis, 1996). Using the D/D scale, 28 patients had no disfigurement, 9 had minor 
disfigurement and 18 had extensive disfigurement. They reported that the extent of 
disfigurement was not significantly correlated with sexual functioning, although there 
was a trend towards poorer sexual functioning in patients with extensive 
disfigurement. They also reported that patients with extensive disfigurement felt more 
unattractive and older. They did not describe the statistical procedures that had been 
applied to their data and did not report any significance values, so it is difficult to 
ascertain how reliable the outcome of this study is.
45
Dropkin (1999) stated that the purpose o f this study was to describe coping ability and 
the degree of post-operative disfigurement in relation to length of hospital stay. 
However, she assessed 117 adults and reported that coping ability decreased with 
anticipation o f disfigurative surgery. It was not clear what procedure she had followed 
to come to this conclusion. In addition, although she assessed the degree of post­
operative disfigurement using the D/D scale, she did not report this in relation to 
length o f hospital stay as had been outlined in her aim. This paper would have 
received the lowest quality grading possible had it not been for the fact that there were 
a large number of patients in the cohort.
In a similarly designed study to that reported two years earlier, Dropkin (2001) 
assessed 75 patients following disfigurative surgery for head and neck cancer to 
determine levels of anxiety. She concluded that, although mean anxiety scores 
decreased over time, there was no significant correlation between disfigurement 
(measured using the D/D scale) and post-operative anxiety. She did not state how she 
had determined this, simply stating that data had been “analysed” and reported no 
significance figures. There were a reasonable number o f patients in the cohort.
Devine et a l (2001) set out to compare the effects o f two surgical procedures for 
previously untreated oral carcinoma on facial appearance. The first surgical technique 
was lip split mandibulotomy (n=10), which involves incision of the lower lip in 
continuity with the neck dissection incision. The second technique was mandible 
release (n=10). The authors did not hypothesise which technique they believed would 
result in a preferable aesthetic outcome. Following the surgical procedure, an overall 
aesthetic assessment of the patient’s face and neck was made by the clinician and
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scored using a seven point linear analogue scale, whereby ‘1’ was ‘highly 
satisfactory’ and ‘7’ was ‘highly unsatisfactory’. Lay observers also scored the overall 
appearance of the patients using photographs and at the end of the clinical 
examination, the patients were asked to score their own face and neck appearance 
using the same scoring system. The authors also administered the disfigurement 
questions from the University of Washington Quality o f Life assessment (UW-QOL) 
(Hassan and Weymuller, 1993).
The authors reported using ANOVA for their comparisons between the groups. This is 
considered hazardous due to the sample sizes being so small and results must be 
interpreted as inconclusive for this reason. They reported that, although the clinician 
tended to rate patients as having a more satisfactory appearance than laypersons or 
patients, there were no significant differences between the groups on any of the 
aesthetic ratings or on the UW-QOL disfigurement questions. Their conclusion was 
that there was no difference in aesthetic outcome between these two procedures.
Kwok et al. (2002) investigated appearance related quality of life in patients treated 
for parotid gland (n=l 3) or temporal bone (n=10) cancer. The parotid gland is situated 
near to the ear, while the temporal bone is the thick bone that encases the inner ear. 
Thus, they compared those who had had temporal bone resection (TBR) to those who 
had had parotidectomy plus radiation (P+RT). Disfigurement was rated on the basis of 
presence or absence of the outer projecting portion of the ear (pinna) and the 
reconstruction flap. In addition patients were asked to rate the impact of their 
appearance changes using two questions, one from the European Organisation for 
Research and Treatment of Cancer Quality of Life Questionnaire (Head and Neck
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specific module) (EORTC QLQ-H&N35) (Bjordal et al., 1994) and one from the 
University o f Washington Quality of Life assessment (UW-QOL) (Hassan and 
Weymuller, 1993).
They used a Mann Whitney test to show that the TBR group had significantly poorer 
cosmetic outcome and lower appearance related quality of life but only on the UW- 
QOL item. There was only a moderate correlation between the UW-QOL appearance 
item and the EORTC QLQ-H&N35 appearance item.
There are several problems with this study. Firstly, the authors based patients’ 
appearance related quality of life on only two questions from different questionnaires. 
They also used a non-standardised, dichotomous (presence or absence) type o f rating 
of disfigurement. In addition, the numbers in each group were very small so caution 
must be taken when accepting these results due to low power.
Conclusions
The era of publication did not appear to influence the quality of the research, with 
fairly poor quality research being carried out as recently as 2001. The major criticisms 
identified in this systematic review of head and neck cancer of the body image / 
appearance research can be summarised as follows:
1. None of the studies identified based their enquiries on a clear definition or 
psychological model of body image or appearance change following head and 
neck cancer.
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2. Researchers tended to use non-standardised or problematic measures of 
observer rated disfigurement. They also used either one or two items from a 
general quality of life questionnaire to assess appearance related quality of 
life, or a non-standardised measure of appearance related quality of life.
3. Quite often studies without groups were employed. In addition, in those 
studies that had used groups, although the groups were often well matched, 
there were often low numbers in each group. In these cases statistical 
procedures were often carried out when the number of patients in each group 
should have precluded this.
In an attempt to overcome some of the problems with observer ratings of 
disfigurement, Katz et al. (2000) developed the observer rated disfigurement scale for 
head and neck cancer. This is a simple nine-point scale with numbers from 1 to 9 
corresponding to extent of disfigurement. It also provides examples of what 
constitutes minimal, moderate and severe disfigurement on the scale (see Appendix 
2.2). If this scale is used for the objective measurement of disfigurement combined 
with improvements in the other areas discussed, then the quality of research in this 
field should improve dramatically.
Overall the research that has examined body image or appearance factors is sparse 
with respect to eye cancer and of poor quality in head and neck cancer. It is therefore 
difficult to draw definite conclusions owing to the paucity o f the literature. Further 
work examining body image dimensions as the main focus of investigation in facial 
cancer is therefore needed, in order that this area is not further neglected. White
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(2000) has applied Higgins’ (1987) self-discrepancy theory and Cash and 
Szymanski’s (1995) work on body image to the cancer field. Here he has proposed a 
heuristic cognitive behavioural model o f body image and cancer. However, this model 
has not yet been empirically tested and therefore research is needed to evaluate it.
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Table 1 -  Quality assessment guidelines1 (based on MacMahon and Lip, 2002).
1 a Prospective, longitudinal studies with sufficient patient numbers, well matched
groups and well validated measurement instruments.
lb  Prospective, longitudinal studies with low patient numbers, but with well-
matched groups and well-validated measurement instruments.
2a Cross sectional studies with sufficient patient numbers, well matched groups
and well validated measurement instruments.
2b Cross sectional studies with low patient numbers, but with well matched
groups and well validated measurement instruments.
3a Prospective, longitudinal studies with sufficient patient numbers, but poorly
matched groups and/or less well validated instruments.
3b Prospective, longitudinal studies with low patient numbers, poorly matched
groups and/or less well validated instruments.
4a Cross sectional studies with sufficient patient numbers, but poorly matched
groups and/or less well validated instruments.
4b Cross sectional studies with low patient numbers, poorly matched groups
and/or less well validated instruments.
5a Prospective, longitudinal studies with sufficient patient numbers, but no
groups and/or less well validated instruments.
5b Prospective, longitudinal studies with low patient numbers, no groups and/or
less well validated instruments.
6a Cross sectional studies with sufficient patient numbers, but no groups and/or
less well validated instruments.
6b Cross sectional studies with low patient numbers, no groups and/or less well
validated instruments.
'Classification developed for studies other than Randomised Controlled Trials 
(RCTs).
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SUMMARY
There are a limited number of studies relating to body image and cancer and they 
have tended to examine it with unsophisticated methods. Cash and Pruzinsky (1990), 
however, defined body image as a more complex construct, which encompasses a 
person’s perceptions, thoughts, feelings, and actions. This research aims to further the 
understanding o f the impact of eye cancer on a patient’s body image by applying the 
‘investment in body ideals’ component of the model proposed by White (2000).
Investment in body ideals is determined by i) the degree to which a person has an 
investment in the changed body feature or features, and ii) the presence o f a 
discrepancy between ideal / self and actual / self. However, it is also proposed that 
receiving a diagnosis of cancer may overshadow concerns over appearance when 
individuals are more concerned with survival than cosmetics. Therefore, investment in 
facial appearance may differ between patients with eye cancer and those with other, 
non-life threatening eye diseases such as thyroid eye disease (TED). These differences 
will be explored in this study using a modified version of the Body Image Ideals 
Questionnaire (BIQ) (Szymanski and Cash, 1995), specifically addressing facial 
appearance, the BIQ-face, plus a modified version of the Appearance Schemas 
Inventory (ASI) (Cash and Labarge, 1996), specifically addressing facial appearance, 
the ASI-face, and the Pictorial Representation of Illness and Self Measure (PRISM) 
(Buchi and Sensky, 1999).
The power calculation is based on normative data for the ASI (Cash and Labarge, 
1996). Using Cohen’s (1992) tables, in the present study 26 participants would be 
required in each group to detect significant differences (p<0.05) on an independent 
samples t-test or ANOVA with power 0.8 and a large Effect Size.
In addition to furthering the understanding of the impact of eye cancer on a patient’s 
body image, the research will also be of specific use to the Consultant 
Ophthalmologist, by helping inform his practice when dealing with issues involving a 
patient’s concerns about facial appearance following surgery.
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INTRODUCTION
Appearance change, body-image, and cancer
There are a limited number of studies relating to appearance change and cancer, with 
the majority of the research being carried out with breast cancer patients. A small 
number o f studies have been carried out with facial cancer patients. Only two papers 
were identified that had sought to measure body image as a principal outcome in an 
eye cancer population. In head and neck cancer, only thirteen studies had aimed to 
systematically evaluate body image / appearance as a principal outcome and the 
quality o f this research was generally poor. This research treated body image as a 
simplistic construct and examined it with unsophisticated methods. However, Cash 
and Pruzinsky (1990), have defined body image as a more complex construct, which 
encompasses a person’s perceptions, thoughts, feelings, and actions.
The Self and Self-Discrepancy Theory
Reber (1995) defines the ‘se lf as “one’s concept of oneself in as complete and 
thorough a description as is possible for one to give”. Similarly Curbow et al. (1990) 
define the term as “a collection o f self-representations”. Markus and Wurf (1987) 
further describe several dimensions that characterise and differentiate self­
representations. For example, ‘valence’ (i.e. positive or negative) and ‘time 
orientation’ (i.e. past, present, future). In this way, if a cancer patient has a self- 
concept that includes a representation of the self on, say a ‘physical strength’ 
dimension, this allows this to be further characterised for that person as, for example, 
‘negative’ and ‘current’.
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It can be seen that both of the above definitions propose that the ‘se lf is multi­
faceted. Rosenberg (1977) proposed that these multiple aspects develop through both 
internal self-evaluations and interpersonal experiences. Thus, it is suggested that 
aspects of the self are dynamic, as in response to external events, different aspects of 
may be changed or modified. It has also been proposed that some self-representations 
are “core”, while others are peripheral (Curbow et al., 1990).
In Higgins’ (1987) Self-Discrepancy, two o f the components that constitute the self 
are ideal / self and actual / self. Ideal / self refers to the aspirations as to who one 
could potentially be, whereas actual / self refers to conceptions as to who one really 
is. Higgins (1987) proposes that the greater the magnitude and accessibility o f a 
particular type of self-discrepancy, the more its owner will experience the kind of 
discomfort associated with it. Individuals are therefore motivated to achieve a match 
between their ideal / self and actual / self because a discrepancy would result in 
psychological distress.
Specifically, if a person possesses a discrepancy between ideal / self and actual / self, 
the current state of his or her attributes does not match the ideal state that he or she 
hopes or wishes to attain. Higgins (1987) proposes that an ideal / actual self­
discrepancy therefore represents the general psychological situation of the absence of 
positive outcomes (i.e. non-obtainment o f one’s hopes and desires). This predicts 
vulnerability to dejection related emotions such as disappointment and dissatisfaction, 
as in psychological analyses of these emotions they have been described as being 
associated with discrepancy from hopes, desires or ideal (e.g. Abelson, 1983;Carver 
and Ganellen, 1983).
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A diagnosis of cancer is particularly threatening to the self because it is associated 
with both fear of pain and death due to the disease, and fears of painful and 
debilitating and possibly disfiguring treatment. Receiving a diagnosis of cancer is 
therefore a particularly potent motivation for engaging in adjustments related to the 
self (Curbow et al., 1990). Self-discrepancy theory proposes, that in response to 
external threatening events (such as a diagnosis o f cancer), aspects o f the self are 
altered in an attempt to maintain an ideal / self - actual / self match, which reduces 
psychological distress and enhances psychological adjustment.
Investment
Cash and Szymanski (1995) highlighted that previous body image research has tended 
to regard all physical attributes as if  they were o f equal importance. They proposed 
that it is the degree to which someone places importance on a perceived ideal / actual 
self-discrepancy that is important, and not merely the discrepancy being present. 
Thus, an ideal / actual self-discrepancy o f major importance (i.e. one that has high 
investment) will have a significant psychological impact, being equivalent to having 
multiple ideal / actual self-discrepancies that are each associated with lesser degrees 
o f importance. By combining the concept of investment with Higgins’ (1987) self­
discrepancy theory, they were able to account for the differential degrees of 
importance that are placed on physical features by different people.
Investment in body ideals
White (2000) proposed a heuristic cognitive behavioural model of body image and 
cancer. One component of the model is ‘investment in body ideals’, which 
incorporates Cash and Szymanski’s (1995) concept of ‘investment’, and Higgins’
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(1987) ‘self-discrepancy theory’. Investment in body ideals is determined by i) the 
degree to which a person has an investment in the changed body feature or features, 
and ii) the presence of an ideal / actual self-discrepancy. Therefore, cancer patients 
with high levels of personal investment in discrete physical attributes should 
experience more negative psychological consequences following changes in that 
attribute than patients experiencing similar objective changes, but who have less 
personal investment in the attribute.
However, receiving a diagnosis o f cancer, which is a life threatening disease, may 
overshadow concerns over appearance when individuals are more concerned with 
survival than cosmetics (Fallowfield et al., 1987, Pozo et al., 1992). In contrast, 
survival is unlikely to be the main concern for those individuals whose facial 
appearance may also change as a result o f surgery, or from treatment, but whose 
diagnosis is not life threatening (e.g. thyroid eye disease (TED) patients). As TED is 
not life threatening, people with TED may be less concerned about whether they are 
going to die.
Given that facial appearance has changed, it is likely that ideal / actual self­
discrepancies relating to the face exist in people with eye disease. However, 
investment in facial appearance is likely to differ between those patients with eye 
cancer and those with other eye diseases such as Thyroid Eye Disease (TED). This 
will be investigated by applying the ‘investment in body ideals’ component of 
White’s (2000) model, which has not yet been empirically tested.
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Hypotheses
1. Participants with eye cancer and TED will have higher levels o f psychological 
distress compared to control participants.
2. Levels of ideal / actual self-discrepancies relating to facial appearance will be 
higher in participants with eye disease (cancer and TED patients) compared to 
control participants.
3. Facial appearance will be more important to TED patients compared to eye cancer 
patients.
4. Patients with eye cancer will be more concerned about their illness than their facial 
appearance and patients with TED will be more concerned about their facial 
appearance than their illness.
METHODOLOGY
Participants
Common inclusion criteria fo r  the eye cancer and thyroid eye disease groups
•  Adult patients who have had their vision corrected following surgery (most 
likely by spectacles).
Additional inclusion criteria fo r  the eye-cancer group
• Adult patients who have a confirmed diagnosis of eye cancer and are aware that 
this is their diagnosis.
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Additional inclusion criteria fo r  the TED group
• Adult patients who have a confirmed diagnosis of Thyroid Eye Disease (TED) and 
are aware that this is their diagnosis.
Inclusion criteria fo r  the Control group
• Controls will be taken from a convenience sample of willing adult volunteers.
• Controls will have normal vision or have had their vision corrected to be normal 
by either spectacles or contact lenses.
Common exclusion criteria fo r  all groups
• People with a previous diagnosis o f eye disease (i.e. for Eye Cancer and TED 
groups, this must be the first time they have had an eye disease, and controls must 
not have had an eye disease before).
Additional exclusion criteria fo r  the Eye-Cancer group
•  People with a previous diagnosis of cancer.
Procedure
Eye-cancer (Eye Cancer group), and thyroid eye disease (TED group) patients 
referred to the Tennent Institute of Ophthalmology service based at the Gartnavel 
General Hospital in Glasgow will be recruited for the study. Participant gender will be 
matched to the gender distribution that occurs in each eye disease. Participants will be 
recruited through the Consultants and medical staff involved in the service. Willing
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potential participants will be contacted by the principal investigator and to identify if 
they meet the inclusion criteria. It will be made clear that participation is voluntary 
and they can withdraw from the research at any time. The nature and procedure of the 
study will be explained to suitable willing participants and an information sheet will 
be provided (Appendix 3.1). Opportunities will be given for participants to ask any 
questions and they will then be asked to sign the consent form (Appendix 3.2). They 
will also be asked to decide whether or not to consent to existing photographic 
material being used for illustrative purposes only. This will be on the understanding 
that all attempts will be made to make the material anonymous. They will receive a 
copy of this consent form once it has been signed by the Doctor. It is anticipated that 
only one appointment will be necessary to collect data and each appointment will take 
approximately 45 minutes to one hour. Control participants will be taken from a 
‘convenience’ sample of the author’s family and friends. Willing participants will be 
asked to complete the following measures:
Measures
B rief Symptom Inventory (BSI) (Derogatis and Melisaraatos, 1983).
This is a familiar 53-item self-report measure o f psychological distress. Each item is 
rated on a 5-point scale of distress from 0 (not at all) to 4 (extremely). The BSI is 
scored and profiled in terms of nine primary symptom dimensions and three global 
indices of distress. The Global Severity Index (GSI) will be used in the present study. 
This is the sum of all items divided by the total number of responses (i.e. 53 when 
there are no missing responses). The GSI is then converted to standardised score to 
enable comparison with a relevant reference group. The scale’s internal consistency 
(alpha) ranges from 0.71 to 0.85 and the test-retest reliability (r) ranges from 0.68 to
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0.91, indicating acceptable reliability. Convergent validity ranges from 0.92 to 0.98, 
which is also deemed satisfactory (Croog et al., 1986).
Hospital Anxiety and Depression Scale (HADS) (Zigmond and Snaith, 1983).
This is to be used in addition to the BSI as it is very familiar and is widely used. It is a 
14-item self-report measure of anxiety (7 items) and depression (7 items). Each item 
is scored on a four point scale (0, 1, 2, 3). The range of scores is therefore 0-21 for the 
anxiety subscale, and 0-21 for the depression subscale. Both the Anxiety subscale and 
the Depression subscale will be computed in the present study. Internal consistency 
(alpha) ranges from 0.80 to 0.93 for the anxiety subscale and 0.81 to 0.90 for the 
depression subscale. Test-retest reliability shows a high correlation of 0.8 (r) o f up to 
two weeks (Herrmann, 1997).
In addition, using both the BSI and HADS provides a way of checking the validity of 
the data provided by comparing that found on each measure independently.
If the scores on the BSI and/or HADS are particularly high these will be discussed 
with the Consultant and patients wishing to be referred for psychological intervention 
will be referred to local services via their GP. This will be outlined to patients at the 
recruitment stage and is also contained in the information sheet.
Appearance Schemas Inventory - (ASI) (Cash and Labarge, 1996) (Appendix 3.3).
This is a 14-item scale designed to assess core beliefs or assumptions about the 
importance, meaning, and effects o f appearance in one’s life. Each item is marked on 
a five point Likert scale, with responses ranging from: “ 1 = Strongly Disagree”, “2 = 
Mostly Disagree”, “3 = Neither Disagree nor Agree”, “4 = Mostly Agree” and “5 =
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Strongly Agree”. The range of mean ASI scores is therefore 1 - 5 .  Examples of items 
are:
1. What I look like is an important part of who I am.
2. What is wrong with my appearance is one of the first things that people will notice
about me.
The ASI mean for the standardisation sample of 274 female college students was 2.61 
(SD = 0.67). The scale’s internal consistency (alpha) is 0.84 for college women, 
indicating acceptable reliability. Convergent and discriminant validity were also 
deemed satisfactory (Cash and Labarge, 1996).
Appearance Schemas Inventory (Face) -  (ASI-face) (Appendix 3.4).
This questionnaire is a modified version of the ASI, developed for this study. The 
authors stated that each applicable item of the ASI could be been re-written to relate 
specifically to facial appearance (Cash, personal communication). They also 
recommended that both original and modified versions be administered, in order that 
further data for the validated version could be gathered. The ASI and ASI-face can 
each be completed in less than 5 minutes.
Body Image Ideals Questionnaire - (BIQ) (Szymanski and Cash, 1995) (Appendix 
3.5).
This is an 11 -item questionnaire designed to assess perceived discrepancy from and 
degree of investment in personal ideals on multiple physical attributes. Using a four 
point Likert scale, the BIQ measures self-discrepancies, and investment o f each 
attribute. The weighted product of these two measurements can also be calculated.
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Currently the measure consists o f 11 items, with only 2 items relating specifically to 
the face. For example:
Item 4 A. My ideal facial features (eyes, nose, ears, facial shape) are: - (response in 
the range “0 = Exactly as I am”, “ 1 = Almost as I am”, “2 = Fairly unlike 
me” and “3 = Very unlike me”).
B. How important to you are your ideal facial features? -  (response in the 
range “0 = Not important”, “ 1 = Somewhat important”, “2 = Moderately 
important” and “3 = Very important”)
The following three mean scores are derived from the BIQ:
1. Mean self-ideal discrepancy score (part a) (note: 0 scores are first converted 
to -1):
Range -1 to +3 (whereby -1 relates to “my ideal is exactly as I am”, and, +3 
relates to “my ideal is very unlike me”).
2. Mean importance score (part b):
Range 0 to +3 (whereby 0 relates to “my ideal is not important”, and, +3 
relates to “my ideal is very important”).
3. Mean weighted score (part a multiplied by part b):
Range -3  to +9 (whereby -3 relates to “my ideal is exactly as I am and is very 
important” - representing very important congruence, and, +9 relates to “my 
ideal is very unlike me and is very important -  representing very important 
discrepancy.
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This scale’s internal consistency (alpha) is 0.82 for college women, indicating 
acceptable reliability.
Body Image Ideals Questionnaire (Face) -  (BIQ-face) (Appendix 3.6).
This questionnaire is a modified version of question 4 of the BIQ, developed for this 
study. The authors stated that Item 4 (ideal facial appearance) could be expanded so 
that the individual facial features were assessed separately (Cash, personal 
communication). They also recommended that both original and modified versions be 
administered, in order that further data for the validated version could be gathered. 
The BIQ and BIQ-face can each be completed in less than 5 minutes.
Pictorial Representation o f  Illness and Se lf Measure (PRISM) and (PRISM+) (Buchi 
and Sensky, 1999) (Appendix 3.7).
This measure yields a quantitative measure of Self-Illness Separation (SIS), which is 
the distance between the centres of two disks, one representing ‘S e lf and one 
representing ‘Illness’ with a range of 0-27cm. The SIS reflects a person’s perception 
of the intrusiveness and controllability o f their illness or its symptoms in relation to 
their life as a whole. PRISM+ is an extension of PRISM using any number o f further 
differently coloured disks. In this study two differently coloured disks will be used: 
one to represent ‘Illness’ and one to represent ‘Facial Appearance’. These will be used 
to represent the relative importance of each in relation to ‘Self. This scale’s test-retest 
reliability (r) is 0.95 and its inter-rater reliability (r) is 0.79 indicating acceptable 
reliability (Buchi et al., in press).
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Clinician-rated Facial Appearance change scale (Appendix 3.8).
This is a single item clinician rated nine point Likert scale developed for this study. It 
is based on the observer-rated disfigurement scale designed by Katz et al. (2000) 
where the inter-rater reliability (r) was 0.91, indicating acceptable reliability. It 
measures the degree o f facial appearance change from “ 1” (minimal) to “9” (severe) 
A clinician who has examined the patient on the day they take part will complete this 
rating scale for each patient.
It was o f concern that asking eye disease patients about their facial appearance may 
increase their anxiety. However, it has been found that the majority of participants in 
this kind of research do not report undue distress as a result o f exposure to 
emotionally salient material (Fallowfield et al., 1987). In their study, in addition to 
administering psychological questionnaires to patients with early breast cancer, they 
also examined the acceptability of these questionnaires from the patient’s perspective. 
Although three patients out of one hundred and two who participated found the 
interview emotionally upsetting, they also reported that it had been helpful. There 
were no other negative findings. One hundred patients stated that they would 
participate in such a study again and many wrote lengthy comments about the 
cathartic release or insight that the exercise had given them. Thus it is felt that in the 
present study, participation may have a therapeutic effect on patients who may have 
few other opportunities to express their emotions in relation to their eye disease.
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Power calculation
This study is a preliminary test of a hypothesis and consequently there was no direct 
comparison study from which to conduct a power calculation. The power calculation 
is based on normative data for the Appearance Schemas Inventory (ASI) (Cash and 
Labarge, 1996), where in a sample of 274 college females the mean score was 2.61 
(SD = 0.67). In the present study a mean difference score of 1 between groups has 
been deemed as a clinically significant difference. This is equivalent to 1/0.67 = 1.49 
standard deviations (SDs). Using Cohen’s (1992) tables, this reflects a large Effect 
Size and therefore 26 participants would be required in each group to detect 
significant differences (p<0.05) on an independent samples t-test or Analysis of 
Variance (ANOVA) with power 0.8. It is accepted that there are limitations in basing 
the calculation for the present study on data for the ASI, as the present study involves 
both genders and a patient population, and the ASI’s population consisted o f college 
females.
Design
Overall the study will utilise a combination of cross-sectional, between and within 
subjects’ designs.
Hypothesis 1
This will use a between subjects design with one factor ‘Participant group’, having 
three levels: Eye Cancer, TED, or Control. The three dependent variables will be the
A
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means o f the Brief Symptom Inventory (GSI), Hospital Anxiety and Depression Scale 
(HADS) (Anxiety subscale) and HADS (Depression subscale).
Hypothesis 2
This will use a between subjects design with one factor ‘Eye Disease’, having two 
levels (present or not present). The dependent variable will be the mean of the Body 
Image Ideals Questionnaire-face (BIQ-face) discrepancy scores.
Hypothesis 3
This will use a between subjects design with one factor ‘Eye Disease Type’, having 
two levels (TED or Cancer). The first and second dependent variables will be the 
mean o f the BIQ-face importance and weighted scores. The third dependent variable 
will be the mean ASI-face score.
Hypothesis 4
This will use a 2x2 mixed subjects design. Eye disease type will form the between 
subjects factor, with two levels (TED or Cancer). Domain will form the within 
subjects factor, with two levels (Facial Appearance and Illness). The dependent 
variable will be mean distances in cm between the ‘S elf disk and the two domain 
levels’ disks on the PRISM.
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Data Analysis
There will be two parts to the data analysis:
1. Descriptive
Here demographic information such as age, gender, diagnosis, occupation and 
marital status, will be described. The means and standard deviations of the data 
obtained will be tabulated / described here.
2. Analytical
Hypotheses 1, 2 and 3 will be analysed using independent samples statistical 
methods. For hypothesis 1 the following means of the three groups (Eye Cancer, 
TED and Control) will be compared: HADS anxiety and depression subscales and 
Brief Symptom Inventory Global Severity Index (GSI). For hypothesis 2 the BIQ- 
face mean discrepancy scores for the two groups (Eye Disease and Control) will 
be compared. For hypothesis 3 the BIQ-face mean importance and weighted 
scores for the two Eye Disease groups will be compared and the mean ASI-face 
scores for the two groups will also be compared.
Hypothesis 4 will be analysed using both within and independent samples 
statistical methods. Self-Illness Separation and Self-Facial Appearance Separation 
will be analysed between and within the two Eye Disease groups (Eye Cancer and 
TED).
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Practical Applications
This research will further the understanding o f the impact of eye cancer on a patient’s 
body image. The research will also be of specific use to the Consultant 
Ophthalmologist to help inform his clinical decision making and general practice 
when dealing with issues involving patients’ concerns about facial appearance 
following surgery.
Timescale
Data Collection: September 2001 -  March 2002.
Statistical Analysis: March 2002 -  April 2002.
Write up: May 2002 — July 2002.
Ethical Approval
This proposal was submitted to the West Ethical Committee on 18th June 2001 and 
received approval on 26th July 2001 (see Appendix 3.9 letter of approval).
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SUMMARY
Purpose: To determine investment in body ideals in relation to facial appearance in patients 
with eye cancer by applying White’s (2000) heuristic cognitive behavioural model of cancer. 
Also to ascertain psychosocial functioning and the relative importance o f illness and facial 
appearance in eye cancer patients’ lives.
Patients and methods: Outpatients referred to the Tennent Institute of Ophthalmology 
service, Gartnavel General Hospital, Glasgow were recruited for the study. A cross-sectional 
design was used. Eye cancer patients were the principal patient group (n=44), Thyroid Eye 
Disease (TED) patients were the eye disease comparison group (n=44) and a convenience 
sample o f non-eye disease participants (n=75) acted as controls. Participants completed the 
Hospital Anxiety and Depression Scale (HADS), Brief Symptom Inventory (BSI), Body 
Image Ideals Questionnaire (BIQ), BIQ-face, Appearance Schemas Inventory (ASI), ASI-face 
and Pictorial Representation of Illness in Self-Measure (PRISM). A clinician-rated appearance 
change scale was also completed for each patient.
Results: TED patients were more distressed than eye cancer patients and controls. Small 
discrepancies between ideal and actual self in relation to facial appearance were present in all 
groups, although eye cancer patients were significantly less concerned about these 
discrepancies than TED patients. The hypothesis that facial appearance would be more 
important for TED patients compared to Eye Cancer patients was supported by outcomes from 
the ASI-face and the BIQ-face weighted score. Eye cancer patients had minimal facial 
appearance change and TED patients moderate. Although both groups assigned their illness 
and facial appearance as equally important, the TED group demonstrated a larger burden of 
suffering due to their illness and facial appearance than eye cancer patients on the PRISM.
Conclusions: These results offer initial support for the investment in body ideals 
component of W hite’s (2000) model, however, further research involving a larger objective 
change in appearance due to cancer is required. It is also proposed that this model could 
feasibly be applied to the study o f other illnesses in which there have been appearance 
changes. The expectations o f the outcome o f PRISM based on assumptions about disease 
involving generic aspects o f illness were incorrect. It is suggested that perhaps the concept of 
“Illness” associated with PRISM was too global for patients to access the cancer specific issue 
of survival in this study. Limitations of the study and recommendations for future research are 
provided.
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1. INTRODUCTION
Cancer of the eye and adnexa1 is a rare form of cancer and is the only ocular disease that 
directly threatens life (Kleinstein and Lehman, 1977). It is associated with a five-year 
mortality rate of 35% and a ten-year mortality rate of nearly 50% (Cruickshanks et a l, 1999; 
Brandberg et al, 2000). Factors that influence treatment choice in eye cancer patients include 
size, extent and location of the tumour. Patients who have medium or large sized tumours that 
are growing can be managed with either radiotherapy or local resection of the tumour. Patients 
who have large tumours that have produced severe visual loss are more likely to be managed 
by enucleation (removal of the eye) followed by a prosthetic orbital implant (Sisley, 1999). No 
differences in survival have been reported between these methods of treatment (Seddon et al., 
1985).
There is evidence to suggest that there is a high prevalence o f psychological disorder in cancer 
patients. For example, Derogatis et al. (1983) found that, using DSM-III criteria (American 
Psychiatric Association, 1980), 47% of cancer patients received a diagnosis. O f these patients, 
85% were experiencing a disorder with depression or anxiety as the central symptom. A more 
recent study of the prevalence of psychological distress o f cancer patients reported an overall 
rate of distress of 20% (Zabora et al., 2001). The authors concluded that there is a great need 
to identify high-risk patients through psychosocial screening in order to provide early 
intervention. Thus, given the distress experienced by many cancer patients, the importance of 
clinicians’ understanding of psychosocial adjustment to cancer has been emphasised 
(Brennan, 2001).
1 For the purposes of this research, “eye cancer” will be used to refer to “eye and adnexa cancer”, whereby 
adnexa are the adjoining anatomical parts of the eye.
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Eye cancer patients like other cancer patients are therefore at risk of developing psychological 
disorders. In addition to having to cope with a life threatening diagnosis, they also have to 
cope with a potentially altered facial appearance as a result o f treatment (Figure la  and lb). 
Therefore, self-concept may also be threatened resulting in disturbances in body image.
INSERT FIGURE 1A AND IB ABOUT HERE
There are a limited number of studies relating to appearance change and cancer, with the 
majority o f this research being carried out with breast cancer patients. A small number of 
studies have been carried out with facial cancer patients. Only two papers were identified that 
had sought to measure body image as a principal outcome in an eye cancer population. In head 
and neck cancer, only thirteen studies had aimed to systematically evaluate body image / 
appearance as a principal outcome and the quality o f this research was generally poor. This 
research treated body image as a simplistic construct and examined it with unsophisticated 
methods. However, Cash and Pruzinsky (1990), have defined body image as a more complex 
construct, which encompasses a person’s perceptions, thoughts, feelings, and actions.
Reber (1995) defines the ‘self as “one’s concept o f oneself in as complete and thorough a 
description as is possible for one to give”. Similarly Curbow et al. (1990) define the term as 
“a collection of self-representations”. Markus and Wurf (1987) further describe several 
dimensions that characterise and differentiate self-representations. For example, ‘valence’ (i.e. 
positive or negative) and ‘time orientation’ (i.e. past, present, future). In this way, if  a cancer 
patient has a self-concept that includes a representation of the self on, say a ‘physical strength’ 
dimension, this allows this to be further characterised for that person as, for example, 
‘negative’ and ‘current’.
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It can be seen that both of the above definitions propose that the ‘se lf is multi-faceted. 
Rosenberg (1977) proposed that these multiple aspects develop through both internal self- 
evaluations and interpersonal experiences. Thus, it is suggested that aspects o f the self are 
dynamic, as in response to external events, different aspects of may be changed or modified. It 
has also been proposed that some self-representations are “core”, while others are peripheral 
(Curbow et al., 1990).
In Higgins’ (1987) Self-Discrepancy, two of the components that constitute the self are ideal / 
self and actual / self. Ideal / self refers to the aspirations as to who one could potentially be, 
whereas actual / self refers to conceptions as to who one really is. Higgins (1987) proposes 
that the greater the magnitude and accessibility of a particular type of self-discrepancy, the 
more its owner will experience the kind of discomfort associated with it. Individuals are 
therefore motivated to achieve a match between their ideal / self and actual / self because a 
discrepancy would result in psychological distress.
Specifically, if a person possesses a discrepancy between ideal / self and actual / self, the 
current state of his or her attributes does not match the ideal state that he or she hopes or 
wishes to attain. Higgins (1987) proposes that an ideal / actual self-discrepancy therefore 
represents the general psychological situation of the absence of positive outcomes (i.e. non- 
obtainment of one’s hopes and desires). This predicts vulnerability to dejection related 
emotions such as disappointment and dissatisfaction, as in psychological analyses of these 
emotions they have been described as being associated with discrepancy from hopes, desires 
or ideal (e.g. Abelson, 1983;Carver and Ganellen, 1983).
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A diagnosis of cancer is particularly threatening to the self because it is associated with both 
fear o f pain and death due to the disease, and fears of painful and debilitating and possibly 
disfiguring treatment. Receiving a diagnosis of cancer is therefore a particularly potent 
motivation for engaging in adjustments related to the self (Curbow et a l,  1990). Self­
discrepancy theory proposes, that in response to external threatening events (such as a 
diagnosis of cancer), aspects of the self are altered in an attempt to maintain an ideal / self - 
actual / self match, which reduces psychological distress and enhances psychological 
adjustment.
Cash and Szymanski (1995) highlighted that previous body image research has tended to 
regard all physical attributes as if they were of equal importance. They proposed that it is the 
degree to which someone places importance on a perceived ideal / actual self-discrepancy that 
is important, and not merely the discrepancy being present. Thus, an ideal / actual-self 
discrepancy of major importance (i.e. one that has high investment) will have a significant 
psychological impact, being equivalent to having multiple ideal / actual self-discrepancies that 
are ^ach associated with lesser degrees of importance. By combining the concept of 
investment with Higgins’ (1987) self-discrepancy theory, they were able to account for the 
differential degrees of importance that are placed on physical features by different people.
Applying Cash and Szymanski’s (1995) work to the cancer field, White (2000) proposed a 
heuristic cognitive behavioural model of body image and cancer. One component o f the model 
is ‘investment in body ideals’, which incorporates ‘investment’, and ‘self-discrepancy theory’. 
Here investment in body ideals is determined by i) the degree to which a person has an 
investment in the changed body feature or features, and ii) the presence of an ideal / actual 
self-ciscrepancy. Therefore, according to the model, cancer patients with high levels of
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personal investment in discrete physical attributes should experience more negative 
psychological consequences following changes in that attribute than patients experiencing 
similar objective changes, but who have less personal investment in the attribute (see Figure 
2). However, this model has not yet been empirically tested and therefore research is needed 
to evaluate it.
INSERT FIGURE 2 ABOUT HERE
Given that facial appearance has changed, it is likely that ideal / actual self-discrepancies 
relating to the face exist in people with eye diseases. However, investment in facial 
appearance is likely to differ between patients with eye cancer and those with other non life 
threatening eye diseases such as Thyroid Eye Disease (TED). Receiving a diagnosis o f cancer 
may overshadow concerns over appearance when individuals are more concerned with 
survival than cosmetics (Fallowfield et al., 1987, Pozo et a l , 1992). In contrast, survival is 
unlikely to be the main concern for those individuals with TED. Although TED is associated 
with exophthlamus (abnormal protrusion or bulging forward of the eye) and in some cases 
radiotherapy or surgery to the eye socket may be required (Figure 3a and 3b), it is not a life 
threatening disease.
INSERT FIGURES 3A AND 3B ABOUT HERE
The present study has applied the ‘investment in body ideals’ component of White’s (2000) 
model to an investigation of the importance of facial appearance in patients with eye cancer. 
The hypotheses are i) participants with eye cancer and TED will have higher levels of 
psychological distress compared to control participants, ii) Levels of ideal / actual self­
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discrepancies relating to facial appearance will be higher in participants with eye disease 
(cancer and TED patients) compared to control participants, iii) Facial appearance will be 
more important to TED patients compared to eye cancer patients, iv) patients with eye cancer 
will be more concerned about their illness than their facial appearance and patients with TED 
will be more concerned about their facial appearance than their illness.
2. METHOD
2.1 Experimental Design
A cross-sectional design was used. Eye cancer patients formed the principal patient group. 
TED patients and non eye disease (Control) participants were comparison groups.
2.2 Participants
Eye cancer (Eye Cancer group), and thyroid eye disease (TED group) outpatients referred to 
the Tennent Institute of Ophthalmology service based at the Gartnavel General Hospital in 
Glasgow were recruited for the study. The Eye Cancer group consisted o f 44 patients (22 
male, 22 female). This represented the natural gender distribution that occurs in this condition, 
(Harris et al., 1998). The mean age was 62.4 years (SD=13.7). Thirty-eight (86.4%) had a 
diagnosis o f choroidal melanoma, 3 (6.8%) iris melanoma, 1 (2.3%) squamous cell carcinoma, 
1 (2.3%) sebaceous gland carcinoma and 1 (2.3%) basal cell carcinoma. Four patients had had 
enucleations. This distribution was as expected (Kleinstein and Lehman, 1977).
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The TED group consisted of 44 patients (8 male, 36 female), i.e. a female to male ratio of 
4.5:1. This also represented the natural gender distribution that occurs in this condition, 
whereby female to male ratios of between 2:1 and 5:1 have been reported (Marcocci et al., 
1989; Perros et al., 1993). The mean age was 53.3 years (SD=13.6).
The control participants (Control group) were taken from a ‘convenience’ sample o f the 
author’s family and friends. The Control group consisted of 75 participants (32 male, 43 
female) and the mean age was 45.6 years (SD=15.9).
The majority o f participants in each group were either married or living with a partner. There 
were more professionals in the control group compared to the eye disease groups and more 
people had never worked or were unemployed in the TED group. In addition, more eye cancer 
patients had retired compared to TED and control participants (see Table 1 for details of these 
demographics).
INSERT TABLE 1 ABOUT HERE
2.3 Measures of psychosocial functioning
2.3.1 B rief Symptom Inventory (BSI) (Derogatis and Melisaraatos, 1983).
This is a familiar 53-item self-report measure of psychological distress. Each item is rated on 
a 5-point scale o f distress from 0 (not at all) to 4 (extremely). The BSI is scored and profiled 
in terms o f nine primary symptom dimensions and three global indices o f distress. The Global 
Severity Index (GSI) was used in the present study. This is the sum of all items divided by the 
total number o f responses (i.e. 53 when there are no missing responses). The GSI is then
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converted to standardised score to enable comparison with a relevant reference group. The 
scale’s internal consistency (alpha) ranges from 0.71 to 0.85 and the test-retest reliability (r) 
ranges from 0.68 to 0.91, indicating acceptable reliability. Convergent validity ranges from 
0.92 to 0.98, which is also deemed satisfactory (Croog et al., 1986).
2.3.2 Hospital Anxiety and Depression Scale (HADS) (Zigmond and Snaith, 1983).
This is a familiar 14-item self-report measure of anxiety (7 items) and depression (7 items) 
and is widely used. Each item is scored on a four point scale (0, 1, 2, 3). The range of scores is 
therefore 0-21 for the anxiety subscale, and 0-21 for the depression subscale. Both the anxiety 
subscale and the depression subscale were computed in the present study. Internal consistency 
(alpha) ranges from 0.80 to 0.93 for the anxiety subscale and 0.81 to 0.90 for the depression 
subscale. Test-retest reliability shows a high correlation of 0.8 (r) of up to two weeks 
(Herrmann, 1997).
2.4 Body image measures
2.4.1 Appearance Schemas Inventory (ASI) (Cash and Labarge, 1996).
This is a 14-item scale designed to assess core beliefs or assumptions about the importance, 
meaning, and effects o f appearance in one’s life. Each item is marked on a five point Likert 
scale, with responses ranging from: “ 1 = Strongly Disagree”, “2 = Mostly Disagree”, “3 = 
Neither Disagree nor Agree”, “4 = Mostly Agree” and “5 = Strongly Agree”. The range of 
mean ASI scores is therefore 1 to 5. The scale’s internal consistency (alpha) was 0.84 for 
college women, indicating good reliability. Convergent and discriminant validity were also 
deemed satisfactory (Cash and Labarge, 1996). For the present study the authors
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recommended that the ASI was administered, in order that further validation data could be 
gathered (Cash, personal communication).
2.4.2 Appearance Schemas Inventory (Face) -  (ASI-face).
This questionnaire is a modified version of the ASI, developed for this study. The authors 
stated that each applicable item of the ASI could be been re-written to relate specifically to 
facial appearance (Cash, personal communication). The ASI and ASI-face can each be 
completed in less than 5 minutes.
2.4.3 Body Image Ideals Questionnaire - (BIQ) (Szymanski and Cash, 1995).
This is an 1 l-item questionnaire designed to assess perceived discrepancy from and degree of 
investment in personal ideals on multiple physical attributes. Using a four point Likert scale, 
the BIQ measures self-discrepancies, and investment of each attribute. The weighted product 
o f these two measurements can also be calculated. Currently the measure consists o f 11 items, 
with only 2 items relating specifically to the face. This scale’s internal consistency (alpha) is
0.82 for college women, indicating good reliability. The authors recommended that the BIQ 
was administered, in order that further validation data could be gathered (Cash, personal 
communication).
2.4.4 Body Image Ideals Questionnaire (Face) -  (BIQ-face).
This questionnaire is a modified version of Item 4 of the BIQ, developed for this study. The 
authors stated that Item 4 (ideal facial appearance) could be expanded so that the individual 
facial features were assessed separately (Cash, personal communication). The BIQ and BIQ- 
face can each be completed in less than 5 minutes.
102
2.5 Additional measures
2.5.1 Pictorial Representation o f  Illness and S e lf Measure (PRISM) and (PRISM+) (Buchi 
and Sensky, 1999).
This measure yields a quantitative measure of Self-Illness Separation (SIS), which is the 
distance between the centres of two disks, one representing ‘S elf and one representing 
‘Illness’ with a range of 0-27cm. The SIS reflects a person’s perception o f the intrusiveness 
and controllability of their illness or its symptoms in relation to their life as a whole. PRISM+ 
is an extension of PRISM using any number of further differently coloured disks. In this study 
two differently coloured disks were used to ascertain the relative importance of ‘Facial 
Appearance’ and ‘Illness’ in Eye Cancer and TED patients’ lives. This scale’s test-retest 
reliability (r) is 0.95 and its inter-rater reliability (r) is 0.79 indicating acceptable reliability 
(Buchi et a l., in press).
2.5.2 Clinician-rated facial appearance change scale
This is a single item clinician rated nine point Likert scale developed for this study. It is based 
on the observer-rated disfigurement scale designed by Katz et al. (2000) where the inter-rater 
reliability (r) was 0.91, indicating acceptable reliability. It measures the degree of facial 
appearance change from “ 1” (minimal) to “9” (severe). A clinician who had examined the 
patient on the day they took part in the present study completed this rating scale for each 
patient in order to obtain an objective measure of their facial appearance change.
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3. RESULTS
3.1 Descriptive statistics
Table 2 presents the means and standard deviations for the scores of the Eye Cancer, TED and 
Control groups on the HADS (Anxiety subscale), HADS (Depression subscale) and BSI 
(Global Severity Index subscale, GSI).
INSERT TABLE 2 ABOUT HERE
Table 3 details the means and standard deviations for the Body Image Ideals Questionnaire- 
face (BIQ-face) and the Appearance Schemas Inventory-face (ASI-face).
INSERT TABLE 3 ABOUT HERE
Table 4 details the means and standard deviations for the mean Discrepancy scores of the 
Body Image Ideals Questionnaire-face (BIQ-face) for the Eye Disease (Eye Cancer and TED 
combined) and Control groups.
INSERT TABLE 4 ABOUT HERE
The mean Separation between the ‘S elf and ‘Facial Appearance’ disks on the PRISM was 
7.60cm (SD=6.29) for the TED group and 13.9cm (SD=12.13) for the Eye Cancer group. The 
mean Separation between the ‘Self and ‘Illness’ disks was 7.42cm (SD=7.71) for the TED
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group and 12.13cm (SD-8.27) for the Eye Cancer group. This is shown graphically in Figure
4.
INSERT FIGURE 4 ABOUT HERE
The mean clinician rating of facial appearance change was 1.95 (SD=1.72) for the Eye Cancer 
group and 4.02 (SD=2.10) for the TED group.
The mean time since diagnosis was 3.3 years (range 0 to 16 years) for the Eye Cancer group 
and 7.9 years (range 0 to 47 years) for the TED group.
3.2 Analytical statistics
Skewness for data was examined for all variables (whereby significance of skewness = 
skewness / standard error of skewness). Where necessary (i.e. significance of skewness greater 
than or equal to 1.96), transformations were carried out by computing the square root o f the 
data (Howitt and Cramer, 2000). The number of participants in the study exceeded that 
outlined in the proposal (i.e. 26 participants in each group) and can therefore be regarded as 
having sufficient power.
3.2.1 Age
A one way between subjects analysis of variance (ANOVA) showed an overall significant 
effect for participant group (F(2j60)=18.02, p<0.01). Scheffe’s range test found that the Eye 
Cancer group’s mean age (62.4, SD=13.7) was significantly higher than that of both the TED 
group (53.3, SD=13.6), p<0.05, and the Control group (45.6, SD=15.9), p<0.01. In addition,
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tie TED group’s mean age was significantly higher than that o f the Control group, p<0.05. A 
correlation matrix for Age and the variables that were to be analysed between participant 
groups was calculated to establish where Age was a co-variate. Age was found to significantly 
o-vary with BIQ-face (discrepancy) (r = -0.162, p<0.05) and ASI-face (r = 0.158, p<0.05).
Fom visual inspection of Table 1, there did not appear to be any further systematic variation 
ir the other demographic variables that might account for any differences between variables.
32.2 Clinician Rating
Sgnificance of the skewness could not be brought to within acceptable limits by transforming 
tk  data, hence non-parametric statistics were employed. A Mann-Whitney U test found that 
tk  clinician rating for facial appearance change in the TED group was significantly higher 
thin the rating for the Eye Cancer group (U=382.5, N l=44, N2=44, z=-5.06, two-tailed 
pO.Ol). Thus the TED group’s facial appearance was significantly more objectively changed 
b) their illness and /or treatment than the Eye Cancer group.
32.3 Time since diagnosis
Significance of the skewness could not be brought to within acceptable limits by transforming 
thi data, hence non-parametric statistics were employed. A Mann-Whitney U test found that 
tk  time since diagnosis was not significantly different between the Eye Cancer and TED 
gnups (U=843.0, N l=44, N2=44, z=-1.044, two-tailed p>0.05).
3.,4 Analysis o f  psychological distress
A me way between subjects analysis of variance (ANOVA) showed an overall significant 
effect for participant group (F(2,i60)=8.38, p<0.01) on the HADS (Anxiety) subscale. Scheffe’s
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range test found that the TED group’s mean score (8.04, SD=4.62) was significantly higher 
than that o f the Eye Cancer group (5.95, SD=4.19), p<0.05 and the Control group (5.08, 
SD=3.08), p<0.01, but no other differences were found. Hence, the TED group were 
significantly more anxious than both the Eye Cancer and Control groups.
A one way between subjects analysis of variance (ANOVA) showed an overall significant 
effect for participant group (F(2,160)= 17.21, p<0.01) on the HADS (Depression) subscale. 
Scheffe’s range test found that the TED group’s mean score (5.68, SD=4.08) was significantly 
higher than that of the Eye Cancer group (3.39, SD=3.04), p<0.05 and the Control group 
(2.12, SD=2.21), p<0.01. The Eye Cancer group’s mean score was also significantly higher 
than that of the Control group, p<0.05. Hence, the TED group were significantly more 
depressed than both the Eye Cancer and Control groups and the Eye Cancer group were 
significantly more depressed than controls.
A one way between subjects analysis of variance (ANOVA) showed an overall significant 
effect for participant group (F(2,i60)=5.59, p<0.01) on the Brief Symptom Inventory (Global 
Severity Index). Scheffe’s range test found that the TED group’s mean score (58.5, SD=12.93) 
was significantly higher than that of the Control group (51.15, SD=11.56), p<0.01 but no 
other differences were found. Hence, the TED group were overall significantly more 
distressed than the Control group and there were no differences between the Eye Cancer group 
and the other groups.
107
3.2.5 The Body Image Ideals Questionnaire (BIQ) and Appearance Schemas Inventory (ASI) 
These measures were administered for purposes o f gathering further data for validation only. 
The data will be reported elsewhere (see Appendix 4.2 for means and standard deviations for 
these two measures).
3.2.6 Body Image Ideals Questionnaire-face (BIQ-face)
An extracted question from BIQ-face is provided here to assist in interpretation:
la) My ideal facial features (eyes) are:
(response in the range “0 = Exactly as I am”, “ 1 = Almost as I am”, “2 =
Fairly unlike me” or “3 = Very unlike me”).
lb ) How important to you are your ideal facial features (eyes)?
(response in the range “0 = Not important”, “ 1 = Somewhat important”, “2 
= Moderately important” or “3 = Very important”).
In this sample, the internal consistency (alpha) for part a) of the BIQ-face was 0.64 indicating 
moderate reliability and 0.83 for part b) indicating good reliability.
The following three scores can be derived from the BIQ-face:
1. Part a) Mean discrepancy score: (note: 0 scores are first converted to -1):
Range -1 to +3 (whereby -1 relates to “my ideal is exactly as I am”, and, +3 relates to “my 
ideal is very unlike me”).
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2. Part b) Mean importance score:
Range 0 to +3 (whereby 0 relates to “my ideal is not important”, and, +3 relates to “my ideal 
is very important”).
3. Part a multiplied by Part b) Mean weighted score:
Range -3  to +9 (whereby -3 relates to “my ideal is exactly as I am and is very important”, 
signifying a very important congruence, and, +9 relates to “my ideal is very unlike me and is 
very important”, signifying a very important discrepancy).
An analysis of covariance (ANCOVA) was applied to the two groups (Eye Disease and 
Controls) in order to see whether there was a difference in BIQ-face mean discrepancy (i.e. 
mean of part a), controlling for age. The main effect of having eye disease or not was not 
significant (F (ij60)= l-36 , p>0.05). The adjusted means are shown in Table 5. Thus there was 
no difference in the level of ideal-actual self discrepancy in relation to the face in eye disease 
patients and non eye disease controls.
INSERT TABLE 5 ABOUT HERE
An independent samples t-test found that the mean BIQ-face importance score (i.e. mean of 
part b) for the TED group (1.57, SD=0.84) was not significantly higher (t=-l .789, df=86, two- 
tailed p>0.05) than that of the Eye Cancer group (1.21, SD=0.99). Thus, TED and Eye Cancer 
groups both reported their mean facial ‘ideal’ as being between “somewhat important” and 
“moderately important”.
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An independent samples t-test found that the mean BIQ-face weighted score (i.e. mean of part 
a multiplied by part b) of the TED group (1.61, SD=1.94) was significantly higher (t=-3.42, 
df=86, two-tailed p<0.01) than that of the Eye Cancer group (0.32, SD=1.57). Thus, the TED 
group had significantly less congruence between ideal-actual self discrepancy presence in 
facial appearance and its importance than the Eye Cancer group.
3.2.7 Appearance Schemas Inventory-face (ASI-face)
In this sample, the internal consistency (alpha) for the ASI-face was 0.85 indicating good 
reliability.
An analysis of covariance (ANCOVA) was applied to the two groups (Eye Cancer and TED) 
in order to see whether there was a difference in ASI-face mean, controlling for age. The main 
effect o f participant group was significant (F(i,85)=6.85, p<0.01). Thus the TED group were 
significantly more facial appearance schematic than the Eye Cancer group. The adjusted 
means are shown in Table 6.
INSERT TABLE 6 ABOUT HERE
3.2.8 PRISM
Significance of the skewness could not be brought to within acceptable limits by transforming 
the data, hence non-parametric statistics were employed.
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i) Relative importance o f  Illness and Facial Appearance within groups (see also Figure 4).
The difference between Self-Facial Appearance separation and Self-Illness separation was not 
significant in the Eye Cancer group (Wilcoxon, N=44, z=-0.860, two-tailed p>0.05). The 
difference between Self-Facial Appearance separation and Self-Illness separation was not 
significant in the TED group (Wilcoxon, N=44, z=-0.159, two-tailed p>0.05). Thus the Eye 
Cancer group assigned their illness and their facial appearance as being equally important in 
their lives. The TED group also assigned their illness and their facial appearance as being 
equally important in their lives.
ii) Relative Importance o f  Illness and Facial appearance between groups (see also Figure 4). 
A Mann-Whitney U test found that the Self-Facial Appearance separation was significantly 
longer for the Eye Cancer group than for the TED group (U=576.5, N l=44, N2=44, z=-3.28, 
two-tailed p<0.01). A second Mann-Whitney U test found that the Self-Illness separation was 
significantly longer for the Eye Cancer group than for the TED group (U=668.5, N l=44, 
N2=44, z=-2.51, two-tailed p<0.05). Thus, the TED group assigned both illness and facial 
appearance as being significantly more important in their life compared to the Eye Cancer 
group.
4. DISCUSSION
TED patients were significantly more anxious, depressed and overall more psychologically 
distressed than the participants in the Eye Cancer and Control groups. However, psychological 
distress has been reported as a feature of hyperthyroidism (Iacovides et al., 2000; Joffe and 
Marriott, 2000). As hyperthyroidism is present in the majority of patients diagnosed with
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TED, this thyroid imbalance may have therefore pre-disposed some TED patients to 
psychological distress, accounting for the higher levels of distress seen in this group.
Although the Eye Cancer group were more depressed than Controls (on HADS depression 
subscale), the mean score was below that deemed to be clinically significant (Zigmond and 
Snaith, 1983). They were also not different to controls on the HADS anxiety subscale or in 
terms of global psychological distress (BSI, GSI). This finding is inconsistent with rates of 
distress in cancer patients reported in the research literature (Derogatis et al. 1983; Zabora et 
al. 2001). However, high psychological distress has been found to be more common in cancer 
diagnoses associated with a poorer prognosis coupled with feelings o f responsibility, such as 
lung cancer (Zabora et al., 2001). Lung cancer has a poorer prognosis than eye cancer and is 
therefore likely to have a more adverse effect on the patient’s life on a day to day basis. In 
addition, lung cancer patients may feel responsible for their diagnosis through lifestyle 
behaviours whereas eye cancer patients would be unlikely to. Self attribution may therefore 
play a critical role in the actual levels of distress of cancer patients (Faller et al., 1995; Faller 
et al., 1996).
It was hypothesised that, as eye cancer patients have to cope with a life threatening diagnosis, 
this may overshadow their concerns over their facial appearance when they are more 
concerned with survival. However, on the PRISM they rated their illness and facial 
appearance as being equally as important to them in their lives as a whole. Survival was felt to 
be an important factor in terms of how eye cancer patients would view their illness compared 
to their facial appearance. However, ‘survival’ was not actually assessed. Perhaps the concept 
o f ‘Illness’ was too global for patients to access the cancer specific issue of survival when 
completing this measure. Therefore, survival is clearly only a part of what constitutes ‘Illness’
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to eye cancer patients. The TED group also rated illness and facial appearance as being 
equally important in their lives on the PRISM, when it was expected that they might view 
their facial appearance as more important. However, they placed both ‘facial appearance’ and 
‘illness’ disks closer to the ‘se lf disk than eye cancer patients. Thus, the expectations o f the 
outcome of PRISM based on assumptions about disease involving generic aspects o f illness 
(i.e. that having cancer is “worse” than having TED), were incorrect. The PRISM showed that 
the burden of suffering due to having TED was significantly higher than it was due to having 
eye cancer, in this sample.
The ‘investment in body ideals’ component of White’s (2000) model is essentially a 
combination of Higgins (1987) self-discrepancy theory and Cash and Szymanski’s (1995) 
theory of investment. Given that facial appearance had changed, it was felt that people with 
eye disease may have higher ideal / actual self-discrepancies in relation to facial appearance 
compared to controls. This was not supported in this sample. Small ideal / actual self­
discrepancies in relation to facial appearance were present in each of the three groups (Eye 
Cancer, TED and Control) and there were no significant differences. However, according to 
Higgins (1987), individuals are motivated to achieve a match between their ideal and actual 
selves in order to facilitate psychological functioning, so it is possible that this is what 
occurred in the present study. The eye cancer group were objectively rated as having only 
minimally visible changes. Therefore, it is possible that, as a result of this ‘floor effect’ o f the 
objective rating, the eye cancer patients in this sample were not qualitatively different to 
controls in terms o f their facial appearance. Thus this low objective rating may have also 
accurately reflected the way the eye cancer patients viewed their facial appearance. However, 
as a rating of facial appearance change from the patient’s point of view was not taken, this has 
to remain as speculation. As the TED group’s facial appearance was rated as being
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significantly more objectively changed than the Eye Cancer group, it might have been 
expected that the TED group would have higher discrepancies between ideal / self and actual / 
self than eye cancer or control participants in relation to the face. However, this was not found 
either, again suggesting that perhaps individuals had reduced the discrepancy between their 
ideal and actual selves. Heidrich (1999) reported increasing age related to more congruence 
between ideal / self and actual / self (i.e. less discrepancy). In the present study, it is therefore 
possible that the congruence between ideal / self and actual / self seen in the TED group was 
due in part to increasing age (the mean age of this group was 53.3.years).
According to White’s (2000) model, the presence of a discrepancy (regardless o f size) is not 
sufficient in itself to produce negative body image emotions such as anxiety and depression. 
The discrepancy has to relate to a high level of investment for negative emotions to be 
experienced. The hypothesis that TED patients would have higher investment in facial 
appearance compared to eye cancer patients was supported by outcomes from the ASI-face 
and the BIQ-face weighted score. Although TED and Eye Cancer groups both reported their 
mean facial ‘ideal’ as being between “somewhat important” and “moderately important”, the 
TED group had significantly less congruence between ideal / actual self-discrepancy presence 
in facial appearance and its importance as measured by the BIQ-face weighted score. In other 
words, although the discrepancy was small in both groups and the importance score was not 
significantly different between the groups, taken together (the weighted effect) the TED group 
were more concerned about their current ideal / actual self-discrepancy with respect to facial 
appearance than the Eye Cancer group.
Therefore, the TED group did have higher investment in their facial appearance than the eye 
cancer group, which was predicted. However, it cannot be stated that this was due to a lesser
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concern regarding their illness, which was the reason for arriving at this hypothesis. They 
viewed their illness and facial appearance as equally important on the PRISM and therefore 
the relationship between illness and appearance is more complex than originally thought.
The TED group also endorsed the ASI-face significantly higher than the Eye Cancer group, 
which showed that they had more affect laden cognitive constructs with respect to facial 
appearance. This means they would be more likely to be affected by body image experiences 
regarding their facial appearance, than eye cancer patients. The TED group’s ASI-face mean 
score was also higher than that obtained by a normative clinical sample identified to have 
‘extreme body image disturbance’ on the ASI (Cash and Labarge, 1996). The strongest 
correlate when developing the ASI was body image affect suggesting that body-image 
dysphoria is increased by appearance-schematicity. In the present study, neither BIQ-face 
(weighted) nor ASI-face were significantly correlated with any measures of distress. However, 
this may be because this was a measure of global distress and not distress specific to body 
image. Hence the link between the ‘investment in body ideals’ component o f the model and 
resultant psychological distress remains unclear. This link between components o f the model 
was not specifically being addressed in this study. However, the findings discussed above 
have provided evidence for the validity o f the ‘investment in body ideals’ component of 
White’s (2000) model.
Limitations o f  the research
There was a wide range in time since diagnosis within both groups. By referring to Figures la  
and lb  it can be seen that this is the same patient, but presenting at different times to the 
clinic. This is a typical example of eye disease presentation, whereby a higher rate o f facial 
appearance change due to the illness may be apparent in the early stages and, following
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treatment will be much less apparent (Moshfeghi, et al., 2000). Consequently, in the present 
study there was a wider range in objective facial appearance change than would have been 
expected if they had been matched in terms of the time since diagnosis. This may also have 
been a confounding factor, as the issues relating to the experience of eye disease are likely to 
have been different for patients at different stages in the progression of their illness and its 
treatment.
No ratings were collected of appearance change as a result o f the eye disease from the 
patient’s point of view. This would have provided a useful comparison in terms of how it 
compared to clinician rating. It would have also helped to establish if there was any 
relationship between ideal / actual self-discrepancy with respect to facial appearance and 
patient rated appearance change. This would have provided an insight into whether or not 
ideal / actual self-discrepancies were being subjectively reduced by patients.
PRISM was designed for use in patients with physical health problems, hence it was felt that 
its use in an eye disease population study was appropriate. However, it would have been 
useful in this study to record qualitative data relating to individual meanings as to why 
patients placed the disks where they did on the board and this was not done. If this procedure 
had been carried out, it would have provided greater insight into the associations made 
between distances placed between Self and Illness and Self and Facial Appearance by patients. 
In particular it would have provided information as to whether or not individuals were 
thinking o f survival.
The authors o f PRISM have acknowledged that, as a measure in its infancy, there are currently 
some limitations in terms of how meaningful the ‘self-illness separation (SIS)’ outcome is
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(Buchi et al. in press). For example, they have established from qualitative interviews with 
patients that low SIS is associated with high intrusiveness of illness and loss of autonomy. 
Howe ver, they state that it remains unclear whether doubling the SIS represents twice as much 
suffering and how this should be interpreted. They postulate that SIS may well be best 
interpreted in terms of several ranges of values, but that this requires further evaluation. In 
addition, there is no clear definition of the ‘se lf provided for patients, although patients do 
not appear to have difficulty in ascertaining what this is and what is required of them in terms 
of completion of the measure.
The limitations of the BIQ and ASI are that those studies that have ascertained their validity 
and reliability to date have used primarily female college students. Thus the generalisability of 
usefulness o f the measures in an illness population must be made with caution. The present 
study has gathered further data for validation of these measures in a mixed gender, illness 
population which will be reported elsewhere. It is hoped that this will provide some evidence 
for the appropriateness of their use in this population in addition to that o f college females. 
The reliability of the modified versions (ASI-face and BIQ-face) ranged from acceptable to 
good in the present study, hence these measures were deemed to be appropriate.
Conclusions and suggestions fo r  future research
Further work is needed with respect to the application of ‘self-discrepancy theory’ and 
‘investment in body ideals’ in cancer patients. In the present study, patients did not have 
higher ideal / actual self-discrepancies relating to facial appearance than people without eye 
disease and in all groups the level of discrepancy was small. It is therefore recommended that 
the model is evaluated with a group of cancer patients who have more observable appearance 
changes in order to gain a better understanding of the mechanisms involved in determining
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ideal / actual self-discrepancies. It would also be useful to carry out further research 
investigating how self-discrepancy ratings vary with participant age.
In future research, it is also recommended that both time since diagnosis and objective rating 
o f appearance change be matched and that a subjective rating of appearance change be taken. 
It would also be helpful to establish longitudinal aspects of self-discrepancies. Currently 
White’s (2000) model does not take these aspects into account. For example, it may be that 
ideal / actual self-discrepancies are higher at the time of diagnosis but then fall with time as 
appearance returns to ‘normal’. However, at the present time this is unclear. If this was found 
to be the case, the model could be modified accordingly. Finally, although this model was 
developed for cancer and not as a model to be applied to other diseases, based on the data in 
this study it could feasibly be applied to other illnesses in which there have been appearance 
changes.
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Table 1. Demographics for the participant sample (n=163).
Participant Group
Eye Cancer TED Control
Marital Status:
N % N % N %
Single 2 4.5 3 6.8 16 21.3
Married / living with partner 33 75 27 61.4 51 68
Divorced / Separated 2 4.5 7 15.9 5 6.7
Widow / Widower 7 15.9 7 15.9 3 4
New SEC1
LI Employers (large) 0 0 0 0 0 0
L2 Managers (large) 0 0 0 0 0 0
L3 Professionals 9 20.4 6 13.7 30 40
L4 Associate professionals 8 18.2 2 4.5 13 17.3
L5 Managers (small) 3 6.8 2 4.5 2 2.7
L6 Higher supervisors 0 0 1 2.3 1 1.3
L7 Intermediate occupations 7 15.9 8 18.2 12 16
L8 Employers (small) 1 2.3 0 0 0 0
L9 Own account 0 0 0 0 2 2.7
L10 Lower supervisors 1 2.3 0 0 2 2.7
LI 1 Craft and related occupations 1 2.3 2 4.5 1 1.3
L12 Semi-routine occupations 7 15.9 8 18.2 4 5.3
L13 Routine occupations 4 9.1 6 13.6 4 5.3
L14 Never worked / long term unemployed 0 0 8 18.2 1 1.3
L15 Full time student 1 2.3 1 2.3 1 1.3
L16 Not stated or inadequately described 2 4.5 0 0 2 2.7
Retired:
Yes 22 50 11 25 8 10.7
No 22 50 33 75 67 89.3
1 Social Economic Classification (ESRC Review of Government Classifications, 1998)
Table 2 Means and standard deviations for measures of psychological distress for the 
participant sample (n=163).
Group HADS 
(Anxiety) Score
HADS 
(Depression) Score
BSI
(Global Severity 
Index)
Eye Cancer 
N=44
5.95 (4.19) 3.39 (3.04) 52.79 (10.69)
TED 8.04 (4.62) 5.68 (4.08) 58.5 (12.93)
N=44
Control 5.08 (3.08) 2X1(2.21) 51.15(77.55)
N=75
Means are shown in bold and Standard Deviations are shown in brackets in italics.
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Table 3. Means and standard deviations for the Body Image Ideals Questionnaire-face 
(BIQ-face) and Appearance Schemas Inventory-face (ASI-face).
Measure Eye Cancer 
N=44
TED
N=44
Control
N=75
BIQ-face (part a) 
(Discrepancy)
0.09 (0.93) 0.48 (0.78) 0.25 (0.88)
BIQ-face (part b) 
(Importance)
1.21 (0.99) 1.57 (0.84) 1.19 (0.83)
BIQ-face (a x b) 
(Weighted)
0.32 (1.58) 1.61 (1.94) 0.39 (1.49)
ASI-face 2.57 (0.83) 3.02 (0.65) 2.30 (0.52)
Means are shown in >old and Standard Deviations are shown in brackets in italics.
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Table 4. -Means and standard deviations for the Mean Discrepancy scores of Body 
Image Ideals Questionnaire-face (BIQ-face) for eye disease and control groups.
BIQ-face Eye Disease Group 
N=88
Control
N=75
Mean discrepancy 0.29 (0.87) 0.25 (0.88)
Means are shown in bold and Standard Deviations are shown in brackets in italics.
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Table 5. Unadjusted and Adjusted means for BIQ-face mean discrepancy score for Eye 
Disease Group and Control group.
BIQ-face mean Eye Disease Group Control
discrepancy score N=88 N=75
Unadjusted 0.29 0.25
Adjusted 0.35 0.18
129
Table 6. Unadjusted and Adjusted means for ASI-face.
Mean Eye Cancer TED
N=44 N=44
Unadjusted 2.57 3.02
Adjusted 2.57 3.01
130
Figure la. Photograph of an Eye Cancer patient before enucleation
Figure lb . Photograph of an Eye Cancer patient after enucleation with prosthetic orbital implant.
Note: Patient consent for the use of these photographs has been given.
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Figure 2 -  A Heuristic Cognitive Behavioural model of cancer (White 2000).
SCHEMA
INVESTMENT IN BODY IDEALS
I am inadequate Looks are everything
IDEAL-SELF 
DISCREPANCY (5)
BODY IMAGE EMOTIONS (8)
E.g. depressed, ashamed
INVESTMENT IN CHANGED 
BODY FEATURE (4)
OBJECTIVE (OR PERCEIVED) 
APPEARANCE CHANGE (1)
COMPENSATORY BEHAVIOUR (9)
E.g. avoid interaction, always put self 
down
APPEARANCE ASSUMPTIONS (6)
E.g. If my husband looks away he does not love me
AUTOMATIC THOUGHTS & IMAGES (7)
E.g. They think I am ugly, image o f people laughing
SELF SCHEMA (2) BODY IMAGE SCHEMA (3)
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Figure 3a. Photograph of a Thyroid Eye Disease patient before surgery.
Figure 3b. Photograph of Thyroid Eye Disease patient after surgery.
Note: Patient consent for the use of these photographs has been given.
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Figure 4. -  Plot of mean PRISM Self-Facial Appearance and Self-Illness separations
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5. SINGLE CASE RESEARCH STUDY - ABSTRACT
Targeting Self-esteem in the Treatment of Social Anxiety: A Single
Case Experimental Design.
Prepared for submission to Behavioural and Cognitive Psychotherapy 
(See Appendix 5.1 for notes to contributors).
Targeting Self-esteem in the Treatment of Social Anxiety: A Single
Case Experimental Design.
Nicola J. Brown 
Department of Psychological Medicine 
University o f Glasgow 
Glasgow 
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Abstract
Brewin (1996) has postulated that the mental representations thought to underlie 
social phobia are more global and more often concern the self than those thought to 
underlie more circumscribed disorders, such as specific phobias. Low self-esteem is 
thus implicated in the origin and maintenance o f social phobia. Fennell (1997) has 
proposed the first cognitive conceptualisation o f low self-esteem, along with an 
integrated treatment programme derived from the model. She emphasises that the 
effectiveness of schema-focused cognitive therapy remains as yet largely untested.
This single case research study involved N, a patient with social phobia. The aim was 
to test Fennell’s (1997) assertion that previous interventions should have some impact 
on the patient’s belief system by the time attention in therapy is directed towards the 
core belief. N ’s core belief was “I am inadequate”. The research design was an 
extension of an A-B-C design (Kazdin, 1982). An additional aim was to establish if 
there was any differential impact o f interventions on social anxiety.
Behavioural interventions significantly reduced social anxiety, but not strength of 
belief in core belief. The core belief had to be directly challenged in order for a 
statistically significant decrease in strength to be obtained. The results suggest that 
without cognitive interventions, an underlying cognitive vulnerability remains, 
predisposing the patient to future relapse. This single case research provides evidence 
for the importance of cognitive interventions directly targeting core belief associated 
with low self-esteem, in the treatment of patients with social phobia.
Key words:
Social phobia, social anxiety, self-esteem, cognitive behaviour therapy, single n.
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Notes for Contributors
Papers, articles and other contributions should be sent to the Editor, Health Bulletin, Scottish 
Executive Health department, Room IE05, St Andrew’s House, Edinburgh EH1 3DE. They 
must be submitted exclusively for Health Bulletin. Acceptance is on the understanding that 
editorial revision may be necessary. All papers are reviewed by the Editor and by peer review, 
referees being drawn from a panel of appropriate professionals. No correspondence can be 
entered into in relation to articles found to be unsuitable and returned to authors.
Potential contributions can be submitted in two ways. Material submitted for publication must 
be typewritten on one side of the paper only, in double spacing and with adequate margins, 
and each page should be numbered. The top typed copy should be submitted, with four other 
copies. We are willing to receive one copy typewritten in the above format and accompanied 
by a disk (Microsoft Word version 98, Excel for tables and figures). All papers should be 
prefaced by a structured Abstract, of about 250 words in length. It should normally contain 
six clearly headed sections entitled Objective, Design, Setting, Subjects, Results and 
Conclusion. The name, appointment and place of work of the authors should be supplied on a 
separate title page. This same page should include the full postal address of one author, to 
whom correspondence and reprints will be directed. There should be adequate references to 
any relevant previous work on the subject; these references should appear at the end of the 
material on a separate page or pages, using the Vancouver style, which in the case of papers 
in journals includes:
Surname and initials of author(s)
Title of paper 
Full name of journal 
Year published 
Volume number
Opening and closing page numbers
Reference to books should similarly include author’s name and initials, full title, edition (if 
necessary), place of publication, publisher’s name, year and, if required, volume number, 
chapter number or page number.
Short Communications. Health Bulletin publishes short communications (not exceeding 
four pages in length) as a separate section, and we aim to offer speedier publication for these. 
Material intended for this section should be submitted in the above form, and the covering 
letter should state the intention.
Copyright. The material in Health Bulletin is copyright. Items may be freely reproduced in 
professional journals, provided that suitable acknowledgement is made and that reproduction 
is not associated with any form of advertising material. In other cases, permission to 
reproduce extracts should be sought through the Editor from HMSO (Copyright Section), 
which controls the copyright.
Proofs
Contributors will receive one set of proofs. This should be read carefully for printer’s errors, 
and any tables, figures and legends should be checked. Alterations should be kept to a 
minimum, and the proofs should be returned promptly.
Reprints
Ten reprints will be supplied free of charge.
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Instructions to Authors
Initial Manuscript Submission. Authors in North America should submit four copies of the 
manuscript (including copies of tables and illustrations) to Dr Jimmie C. Holland, Memorial 
Sloan-Kettering Cancer Center, 1275 York Avenue, New York 10021, USA. All other 
manuscripts should be submitted to Dr Maggie Watson, Department of Psychological 
Medicine, The Royal Marsden Hospital, Downs Road, Sutton, Surrey, SM2 5PT, UK.
Authors must also supply:
• an electronic copy of the final version (see section below),
• a Copyright Transfer Agreement with original signature(s) - without this we are 
unable to accept the submission, and
• permission grants - if the manuscript contains extracts, including illustrations, from 
other copyright works (including material from on-line or intranet sources) it is the 
author's responsibility to obtain written permission from the owners of the publishing 
rights to reproduce such extracts using the Wiley Permission Request Form. 
Permission grants should be submitted with the manuscript.
Submitted manuscripts should not have been previously published and should not be 
submitted for publication elsewhere while they are under consideration by Wiley. Submitted 
material will not be returned to the author unless specifically requested.
Electronic submission. The electronic copy of the final, revised manuscript must be sent to 
the Editor together with the paper copy. Disks should be PC or Mac formatted; write on the 
disk the software package used, the name of the author and the name of the journal. We are 
able to use most word processing packages, but prefer Word or WordPerfect
Illustrations must be submitted in electronic format where possible. Save each figure as a 
separate file, in TIFF or EPS format preferably, and include the source file. Write on the disk 
the software package used to create them; we favour dedicated illustration packages over 
tools such as Excel or Powerpoint.
Manuscript Style. The language of the journal is English. All submissions including book 
reviews must have a title, be printed on one side of the paper, be double-line spaced and have 
a margin of 3cm all round. Illustrations and tables must be printed on separate sheets, and not 
be incorporated into the text.
• The title page must list the full title, short title of up to 70 characters and names and 
affiliations of all authors. Give the full address, including email, telephone and fax, of 
the author who is to check the proofs.
• Include the name(s) of any sponsor(s) of the research contained in the paper, along 
with grant number(s).
Supply a summary of up to 200 words for all articles [except book reviews]. A summary is a 
concise summary of the whole paper, not just the conclusions, and is understandable without 
reference to the rest of the paper. It should contain no citation to other published work.
All abbreviations except for SI symbols should be written in full the first time they appear. 
Generic or clinical names should be used for all compounds: materials and products should be 
identified. The species of any animals used should be stated precisely. Sources of unusual 
materials and chemicals, and the manufacturer and model of equipment should be indicated.
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Materials and products should be identified in the text by the generic name followed by the 
trade name in brackets.
Reference Style. References should be quoted in the text as name and year within brackets 
and listed at the end of the paper alphabetically. All references must be complete and 
accurate. Online citations should include date of access. Use MedLine abbreviations for 
journal names. They can be found at: http://www.ncbi.nlm.nih.gov/entrez/jrbrowser.cgi. If 
necessary, cite unpublished or personal work in the text but do not include it in the reference 
list. References should be listed in the following style:
Brown GM, Reichlin S. (1972). Psychologic and neural regulation of growth 
hormone secretion. Br J  Psychiatry 34: 45-61.
Cox T, Cox S. (1983). The role of adrenals on the psychophysiology of stress. In 
Current Issues in Clinical Psychology, Karas E. (ed). Plenum Press: London, 3-12.
Lazarus R. (1996). Patterns o f Adjustment. McGraw-Hill: New York.
Illustrations. Supply each illustration on a separate sheet. Write the lead author’s name and 
the figure number on the reverse, with the top of the figure clearly indicated. Supply original 
photographs; photocopies or previously printed material will not be used. Line artwork must 
be high-quality laser output (not photocopies). Tints are not acceptable. Lettering must be of a 
reasonable size that would still be clearly legible upon reduction, and consistent within each 
figure and set of figures. Supply artwork at the intended size for printing. The artwork must 
be sized to the text width of 75 mm one column or 155 mm two columns.
Colour illustrations will not be accepted.
Copyright. To enable the publisher to disseminate the author’s work to the fullest extent, the 
author must sign a Copyright Transfer Agreement, transferring copyright in the article from 
the author to the publisher, and submit the original signed agreement with the article 
presented for publication. A copy of the agreement to be used (which may be photocopied) 
can be found in the first issue of each volume of Psycho-Oncology. Copies may also be 
obtained from the journal editor or publisher, or may be printed from this website.
Further Information. Proofs will be sent to the author for checking. This stage is to be used 
only to correct errors that may have been introduced during the production process. Prompt 
return of the corrected proofs, preferably within two days of receipt, will minimise the risk of 
the paper being held over to a later issue. 25 complimentary offprints will be provided to the 
author who checked the proofs, unless otherwise indicated. Further offprints and copies of the 
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THIS SHEET HAS BEEN APPROVED BY THE WEST ETHICS 
COMMITTEE 
INFORMATION SHEET FOR PATIENTS/VOLUNTEERS IN CLINICAL 
RESEARCH PROJECT
Brief Title o f Project:
The importance of facial appearance in patients with eye cancer
You have been invited to participate in a study being carried out by the Department of 
Psychological Medicine at the University of Glasgow. The main aim o f this study is to 
understand more about how a person’s body image (i.e. perceptions, thoughts, 
feelings and actions about the way one looks) is affected by having experienced eye 
cancer. In addition we are interested in how people who have experienced other eye 
diseases (specifically thyroid eye disease) or no eye disease differ in terms of their 
body image to people who have had eye cancer.
Purpose of Study
There is currently little known about the effects of having eye disease on a person’s 
body image. The aim of this study is to help us to understand more about how having 
a change in facial appearance affects different people in different ways.
Procedure
If you choose to participate in this study you will be asked to sign a consent form 
indicating that you have chosen to take part. You will then be asked to complete 
several questionnaires relating to body image.
(For eye disease patients):
You will also be asked to consider the relative importance of your eye disease and 
your facial appearance in your life.
The involvement in this study will take about 45 minutes to one hour o f your time.
Your participation in this study may be of no direct benefit to you, but could help in 
the development of treatments for future patients. Your GP will be informed that you 
have taken part in the study, however, all information you give as part of this research 
will be confidential. If any of your responses indicate that your mood is very low or 
that you are very distressed your consultant will be notified. If you do not wish to 
participate in this study or you wish to withdraw at any time after commencing, your 
care will in no way be affected. If you want to discuss the research further or you have 
any questions which you would like answered then please contact: Ms Nicola Brown, 
Department of Psychological Medicine, Academic Centre, Gartnavel Royal Hospital, 
1055 Great Western Road, Glasgow; Tel: 0141 211 3920.
Thank you for your interest in the study.
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WEST ETHICS COMMITTEE
FORM OF CONSENT FOR PATIENTS/VOLUNTEERS IN CLINICAL RESEARCH 
PROJECT
Title of Project:
The Importance of Facial Appearance in Patients with Eye Cancer
By signing this form you give consent to your participation in the project whose title 
is at the top o f this page. You should have been given a copy o f the patient 
information sheet approved by the West Ethics Committee to read and to keep. Even 
though you have agreed to take part in the research procedures you may withdraw this 
consent at any time without the need to explain why and without any prejudice to your 
care.
Consent:
I,
(PRINT)
O f...............................................................................................................................................
(Address)
Give my consent to the research procedures above, the nature, purpose and possible 
consequences of which have been described to me
By Ms Nicola Brown, Trainee Clinical Psychologist..........................................
I also consent to photographic material being used in this research and I understand 
that all attempts will be made to make this material anonymous (if published):
YES / NO (delete one)
Patient’s signature.................................................................................. Date
Doctor’s signature
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THE APPEARANCE SCHEMAS INVENTORY (Cash and Labarge, 1996)
ndicate your beliefs about the 14 items below using the 1 to 5 scale (write each rating in the space provided).
1 2 3 4 5
| Strongly Mostly Neither Mostly Strongly
! Disagree Disagree Disagree nor Agree Agree
Agree
Score:
1 to 5
What I look like is an important part of who I am. ............
What’s wrong with my appearance is one o f the first things that people will notice about me...............
One’s outward physical appearance is a sign of the character o f the inner person. ............
If I could look just as I wish, my life would be much happier. ............
If  people knew how I really look, they would like me less. ............j
By controlling my appearance,
I can control many of the social and emotional events in my life. ............
|My appearance is responsible for much of what has happened to me in my life. ............
I should do whatever I can to always looks my best. ............
Ageing will make me less attractive..................................................................................................... ............
fo r  women: To be feminine, a woman must be as pretty as possible. ............
For men: To be masculine, a man must be as handsome as possible. ............
The media’s messages in our society make it impossible for
me to be satisfied with my appearance................................................................................................. ............
The only way I could ever like my looks would be to change what I look like..........................................
Attractive people have it all................................................................................................................................
Homely people have a hard time finding happiness........................................................................... ............
i147
r  THE APPEARANCE SCHEMAS INVENTORY -  FACE
tI
Indicate your beliefs about the 14 items below using the 1 to 5 scale (write each rating in the space provided).
1 2 3 4 5
Strongly Mostly Neither Mostly Strongly
Disagree Disagree Disagree nor Agree Agree
Agree
Score:
1 to 5
1. What my eyes look like is an important part of who I am.......................................................... ............
2. What’s wrong with my eyes is one o f the first things that people will notice about me....................
3. One’s outward physical appearance is a sign o f the character o f the inner person. ............
4. If my eyes could look just as I wish, my life would be much happier. ............
5. If people knew how my eyes really look, they would like me less. ............
6. By controlling the appearance of my face,
I can control many of the social and emotional events in my life. ............
7. My facial appearance is responsible for much of what has happened to me in my life......................
8. I should do whatever I can to always make sure my face looks its best. ............
9. Ageing will make my face less attractive. ............
10. For women: To be feminine, a woman must be as pretty as possible....................................... ............
For men: To be masculine, a man must be as handsome as possible. ............
11. The media’s messages in our society make it impossible for
me to be satisfied with my facial appearance. ............
12. The only way I could ever like my face would be to change what I look like......................... ............
13. Attractive people have it all.........................................................................................................................
14. Homely people have a hard time finding happiness.................................................................................
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THE BODY IMAGE IDEALS QUESTIONNAIRE (BIQ)
(Cash and Szymanski, 1995)
Each item on this questionnaire deals with a different physical characteristic. For each 
characteristic, think about how you would describe yourself as you actually are. Then 
think about how you wish you were. The difference between the two reveals how 
close you come to your personal ideal. In some instances, your looks may closely 
match your ideal. In other instances, they may differ considerably. On part A o f each 
item, you will rate how much you resemble your personal physical ideal by circling 
the number on the 0 to 3 scale.
Your physical ideals may differ in how important they are to you, regardless o f how 
close you come to having them. You may feel strongly that some ideals embody the 
way you want to look or to be. In other areas, your ideals may be less important to 
you. On part B of each item, rate how important your ideal is to you by circling the 
number on the 0 to 3 scale.
1. A. My ideal height is:
0 1 2 3
Exactly Almost Fairly Very
As I Am As I Am Unlike Me Unlike me
B. How important to you is your ideal height?
0 1 2 3
Not Somewhat Moderately Very
Important Important Important Important
2. A. My ideal skin complexion is:
0 1 2 3
Exactly Almost Fairly Very
As I Am As I Am Unlike Me Unlike me
B. How important to you is your ideal skin complexion?
0 1 2 3
Not Somewhat Moderately Very
Important Important Important Important
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3. A. My ideal hair texture and thickness are:
0 1 2  3
Exactly Almost Fairly Very
As I Am As I Am Unlike Me Unlike me
B. How important to you is your ideal hair texture and thickness?
0 1 2 3
Not Somewhat Moderately Very
Important Important Important Important
A. My ideal facial features (eyes, nose, ears, facial shape) are:
0 1 2 3
Exactly Almost Fairly Very
As I Am As I Am Unlike Me Unlike me
B. How important to you are your ideal facial features (eyes, nose, ears, facial
shape)?
0 1 2 3
Not Somewhat Moderately Very
Important Important Important Important
A. My ideal muscle tone and definition is:
0 1 2 3
Exactly Almost Fairly Very
As I Am As I Am Unlike Me Unlike me
B. How important to you is your ideal muscle tone and definition?
0 1 2 3
Not Somewhat Moderately Very
Important Important Important Important
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A. My ideal body proportions are:
0 1 2 3
Exactly Almost Fairly Very
As I Am As I Am Unlike Me Unlike me
B. How important to you are your ideal body proportions?
0 1 2 3
Not Somewhat Moderately Very
Important Important Important Important
A. My ideal weight is:
0 1 2 3
Exactly Almost Fairly Very
As I Am As I Am Unlike Me Unlike me
B. How important to you is your ideal weight?
0 1 2 3
Not Somewhat Moderately Very
Important Important Important Important
A. My ideal chest size is:
0 1 2 3
Exactly Almost Fairly Very
As I Am As I Am Unlike Me Unlike me
B. How important to you is your ideal chest size?
0 1 2 3
Not Somewhat
Important Important
Moderately
Important
Very
Important
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A. My ideal physical strength is:
0 1 2 3
Exactly Almost Fairly Very
As I Am As I Am Unlike Me Unlike me
B. How important to you is your ideal physical strength?
0 1 2 3
Not Somewhat Moderately Very
Important Important Important Important
A. My ideal physical co-ordination is:
0 1 2 3
Exactly Almost Fairly Very
As I Am As I Am Unlike Me Unlike me
B. How important to you is your ideal physical co-ordination?
0 1 2 3
Not Somewhat Moderately Very
Important Important Important Important
A. My ideal overall physical appearance is:
0 1 2 3
Exactly Almost Fairly Very
As I Am As I Am Unlike Me Unlike me
B. How important to you is your overall ideal physical appearance?
0 1 2 3
Not Somewhat Moderately Very
Important Important Important Important
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THE BODY IMAGE IDEALS QUESTIONNAIRE (FACE) -  (BIQ-FACE)
Each item on this questionnaire deals with a different facial characteristic. For each 
characteristic, think about how you would describe yourself as you actually are. Then 
think about how you wish you were. The difference between the two reveals how 
close you come to your personal ideal. In some instances, your looks may closely 
match your ideal. In other instances, they may differ considerably. On part A o f each 
item, you will rate how much you resemble your personal physical ideal by circling 
the number on the 0 to 3 scale.
Your facial ideals may differ in how important they are to you, regardless o f how 
close you come to having them. You may feel strongly that some ideals embody the 
way you want to look or to be. In other areas, your ideals may be less important to 
you. On part B of each item, rate how important your ideal is to you by circling the 
number on the 0 to 3 scale.
1. A. My ideal facial features (eyes) are:
0 1 2 3
Exactly Almost Fairly Very
As I Am As I Am Unlike Me Unlike me
B. How important to you are your ideal facial features (eyes)?
0 1 2 3
Not Somewhat Moderately Very
Important Important Important Important
A. My ideal facial feature (nose) is:
0 1 2 3
Exactly Almost Fairly Very
As I Am As I Am Unlike Me Unlike me
B. How important to you is your ideal facial feature (nose)?
0 1 2 3
Not Somewhat Moderately Very
Important Important Important Important
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3. A. My ideal facial features (ears) are:
0 1 2  3
Exactly 
As I Am
Almost 
As I Am
Fairly 
Unlike Me
Very
Unlike me
B. How important to you are your ideal facial features (ears)?
0 1 2 3
Not
Important
Somewhat
Important
Moderately
Important
Very
Important
A. My ideal facial shape is:
0 1 2 3
Exactly 
As I Am
Almost 
As I Am
Fairly 
Unlike Me
Very
Unlike me
B. How important to you is your ideal facial shape?
0 1 2 3
Not Somewhat
Important Important
Moderately
Important
Very
Important
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STANDARD INSTRUCTIONS FOR PRISM AND PRISM+
(Buchi and Sensky, 1999)
We would like to understand better how your illness [mention the illness] affects 
your life at the moment.
Pd like you to imagine that this white board represents your life as it is now.
The yellow disk in the bottom right corner represents your “self,” and this red 
disk represents your illness.
Where would you put your illness -  the red disk -  in your life at the moment? 
[Hand red disk to patient]
(Most people have an intuitive idea of where to place the illness disk, but if someone 
does not appear to understand the above instructions, go to those below:)
As this may be a rather unusual way of showing the place of your illness in your life, 
let me give you another example:
The blue disk represents your work or your job. For some people, work is an essential 
part of their lives and makes all the difference in how they see themselves. Such a 
person would put the “Work” disk on top of the “Self’ disk [demonstrate this]. For 
other people, work is not that important. For example, they may work just to earn 
money. Such a person would place the “work” disk quite far from the “S elf’ disk 
[demonstrate].
Where would you put your illness -  the red disk -  in your life at the moment? [Hand 
red disk to patient]
(Measure the distance between the centres of the two disks -  the Self-Illness 
Separation (SIS)).
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OF TH E NORTH GLASGOW  UNIVERSITY HOSPITALS NHS TRUST
Our Ref: AHT
WEST ETHICS COMMITTEE 
Western Infirmary 
Dumbarton Road
Glasgow G il 6NT
Your Ref:
Please reply to: Mrs A H Torrie
Direct Line: 2 11 6238 
Fax: 211 1920
SECRETARY - WEST ETHICS COMMITTEE
26 July. 2001
Miss Nicola Brown 
Trainee Clinical Psychologist 
Department o f Psychological Medicine 
Gartnavel Royal Hospital 
1055 Great Western Road 
Glasgow, G12
Dear Miss Brown,
01/106(2) Nicola Brown et al -  The im portance of facial appearance in patients with eye cancer.
The Committee at the meeting held on Tuesday 24 July, 2001, discussed the above study and approved 
both the study design and P.I.S. The Committee require a sentence added to the Patient Information 
Sheet in respect of the patient’s GP being informed of their taking part in the study. This minor 
amendment should come back to me for filing. This study was given full approval.
Please note that the approval contained in this letter is valid for all sites which form part of the North 
Glasgow Trust. If however, this research is to be carried out at sights within the North Glasgow Trust 
other than the one covered by this letter, then a covering letter signed by the person responsible for the 
research on that site should be sent listing names, titles and addresses of all collaborating researchers.
A copy o f this approval letter should also be passed to them.
It should be noted that although Ethics Committee approval has been granted, Trust Management 
approval is still required. This should be obtained through the Research & Development Office at 
Gartnavel General Hospital (Miss W Burton tel No. 0115).
Due to the large volume o f trivial and expected Serious Adverse Events (SAEs) being reported to the 
Committee, the Committee has taken the decision that they only wish to review SAEs where they are 
serious and unexpected and where the investigator believes them to be unusual for the study 
under consideration.
In situations where the study has a Data Monitoring Committee, then the Ethics Committee would only 
require sight of the summarised data at regular intervals of 6 months rather than individual reports.
In respect of MREC approved studies, only events which fall into the above categories and have 
occured at our local site should be passed to the Committee. All other events should be reviewed by 
MREC and should not come before this Committee.
The Committee would like to remind investigators that a copy of the Patient Information Sheet and 
Consent Form should be given to patient/volunteers for retaining.
incorporating the Western Infirmary, Gartnavel General Hospital.
Fhe Glasgow Homoeopathic Hospital, Drumchapel Hospital and Blawarthill Hospital
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This Committee conforms to and abides by the ICH Guideline for Good Clinical Practice.
Kind regards.
Yours sincerely,
Andrea H Torrie
SECRETARY - WEST ETHICS COMMITTEE
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Pages
160-161
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Instructions to Authors
Initial Manuscript Submission. Authors in North America should submit four copies of the 
manuscript (including copies of tables and illustrations) to Dr Jimmie C. Holland, Memorial 
Sloan-Kettering Cancer Center, 1275 York Avenue, New York 10021, USA. All other 
manuscripts should be submitted to Dr Maggie Watson, Department of Psychological 
Medicine, The Royal Marsden Hospital, Downs Road, Sutton, Surrey, SM2 5PT, UK.
Authors must also supply:
• an electronic copy of the final version (see section below),
• a Copyright Transfer Agreement with original signature(s) - without this we are 
unable to accept the submission, and
• permission grants - if the manuscript contains extracts, including illustrations, from 
other copyright works (including material from on-line or intranet sources) it is the 
author's responsibility to obtain written permission from the owners of the publishing 
rights to reproduce such extracts using the Wiley Permission Request Form. 
Permission grants should be submitted with the manuscript.
Submitted manuscripts should not have been previously published and should not be 
submitted for publication elsewhere while they are under consideration by Wiley. Submitted 
material will not be returned to the author unless specifically requested.
Electronic submission. The electronic copy of the final, revised manuscript must be sent to 
the Editor together with the paper copy. Disks should be PC or Mac formatted; write on the 
disk the software package used, the name of the author and the name of the journal. We are 
able to use most word processing packages, but prefer Word or WordPerfect
Illustrations must be submitted in electronic format where possible. Save each figure as a 
separate file, in TIFF or EPS format preferably, and include the source file. Write on the disk 
the software package used to create them; we favour dedicated illustration packages over 
tools such as Excel or Powerpoint.
Manuscript Style. The language of the journal is English. All submissions including book 
reviews must have a title, be printed on one side of the paper, be double-line spaced and have 
a margin of 3cm all round. Illustrations and tables must be printed on separate sheets, and not 
be incorporated into the text.
• The title page must list the full title, short title of up to 70 characters and names and 
affiliations of all authors. Give the full address, including email, telephone and fax, of 
the author who is to check the proofs.
• Include the name(s) of any sponsor(s) of the research contained in the paper, along 
with grant number(s).
Supply a summary of up to 200 words for all articles [except book reviews]. A summary is a 
concise summary of the whole paper, not just the conclusions, and is understandable without 
reference to the rest of the paper. It should contain no citation to other published work.
All abbreviations except for SI symbols should be written in full the first time they appear. 
Generic or clinical names should be used for all compounds: materials and products should be 
identified. The species of any animals used should be stated precisely. Sources of unusual 
materials and chemicals, and the manufacturer and model of equipment should be indicated.
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Materials and products should be identified in the text by the generic name followed by the 
trade name in brackets.
Reference Style. References should be quoted in the text as name and year within brackets 
and listed at the end of the paper alphabetically. All references must be complete and 
accurate. Online citations should include date of access. Use MedLine abbreviations for 
journal names. They can be found at: http://www.ncbi.nlm.nih.gov/entrez/jrbrowser.cgi. If 
necessary, cite unpublished or personal work in the text but do not include it in the reference 
list. References should be listed in the following style:
Brown GM, Reichlin S. 1972. Psychologic and neural regulation of growth hormone 
secretion. BR JPsychiatry 34: 45-61.
Cox T, Cox S. 1983. The role of adrenals on the psychophysiology of stress. In 
Current Issues in Clinical Psychology, Karas E. (ed). Plenum Press: London, 3-12.
Lazarus R. Patterns o f Adjustment. McGraw-Hill: New York, 1976
Illustrations. Supply each illustration on a separate sheet. Write the lead author’s name and 
the figure number on the reverse, with the top of the figure clearly indicated. Supply original 
photographs; photocopies or previously printed material will not be used. Line artwork must 
be high-quality laser output (not photocopies). Tints are not acceptable. Lettering must be of a 
reasonable size that would still be clearly legible upon reduction, and consistent within each 
figure and set of figures. Supply artwork at the intended size for printing. The artwork must 
be sized to the text width of 75 mm one column or 155 mm two columns.
Colour illustrations will not be accepted.
Copyright. To enable the publisher to disseminate the author’s work to the fullest extent, the 
author must sign a Copyright Transfer Agreement, transferring copyright in the article from 
the author to the publisher, and submit the original signed agreement with the article 
presented for publication. A copy of the agreement to be used (which may be photocopied) 
can be found in the first issue of each volume of Psycho-Oncology. Copies may also be 
obtained from the journal editor or publisher, or may be printed from this website.
Further Information. Proofs will be sent to the author for checking. This stage is to be used 
only to correct errors that may have been introduced during the production process. Prompt 
return of the corrected proofs, preferably within two days of receipt, will minimise the risk of 
the paper being held over to a later issue. 25 complimentary offprints will be provided to the 
author who checked the proofs, unless otherwise indicated. Further offprints and copies of the 
journal may be ordered. There is no page charge to authors.
Copyright © 2002 John Wiley & Sons, Inc. All rights reserved.
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Means and standard deviations for the Appearance Schemas Inventory (ASI) for the 
participant sample (n= 163).
Eye Cancer TED Control
N=44 N=44 N=75
ASI mean 2.63 (0.76) 2.90 (0.70) 2.44 (0.53)
Means are shown in jold and Standard Deviations are shown in brackets in italics.
Means and standard deviations for the Body Image Ideals Questionnaire (BIQ) for the 
participant sample (n= 163).
BIQ Eye Cancer 
N=44
TED
N=44
Control
N=75
Mean discrepancy 0.65 (0.85) 0.87 (0.72) 0.89 (0.64)
Mean Importance 1.3 (0.75) 1.60 (0.72) 1.35 (0.67)
Weighted 1.23 (1.62) 2.16 (1.68) 1.41 (1.28)
Means are shown in jold and Standard Deviations are shown in brackets in italics.
